ID,level_one,level_two,level_three,level_four,level_five,total_male_dalys,total_male_dalys_lo,total_male_dalys_hi,total_female_dalys,total_female_dalys_lo,total_female_dalys_hi,total_both_dalys,total_both_dalys_lo,total_both_dalys_hi,relative_both_dalys,all_age_percentchange_male,all_age_percentchange_female,all_age_percentchange_both,age_standardized_male,age_standardized_female,age_standardized_both,age_standardized_percentchange_male,age_standardized_percentchange_female,age_standardized_percentchange_both
1,All causes,NA,NA,NA,NA,1340000,1240000,1460000,1160000,1040000,1290000,2500000,2290000,2740000,1,−1.4% (−3.0 to 0.1),−1.6% (−3.5 to 0.2),−1.5% (−3.1 to 0.1),35834.3 (33218.6 to 38740.3),29934.6 (26981.7 to 33211.3),32796.9 (30041.9 to 35849.3),−15.9% (−17.2 to −14.6) *,−16.7% (−18.3 to −15.1) *,−16.2% (−17.6 to −14.8) *
2,All causes,"Communicable, maternal, neonatal, and nutritional diseases",NA,NA,NA,362000,345000,384000,334000,314000,357000,696000,660000,740000,0.2784,−25.8% (−27.9 to −23.6) *,−27.0% (−29.1 to −24.8) *,−26.4% (−28.4 to −24.3) *,10106.6 (9630.6 to 10695.2),9601.9 (9073.8 to 10240.7),9853.3 (9349.7 to 10459.3),−31.5% (−33.4 to −29.4) *,−32.9% (−34.8 to −30.9) *,−32.2% (−34.0 to −30.3) *
3,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,NA,NA,35100,30900,40400,30800,27700,34400,65900,58700,74700,0.02636,−40.4% (−434 to −37.0) *,−50.0% (−52.7 to −46.9) *,−45.3% (−48.0 to −42.0) *,918.3 (799.5 to 1074.4),828.2 (735.9 to 937.9),874.1 (767.5 to 1006.2),−46.1% (−49.3 to −42.5) *,−54.7% (−57.4 to −51.6) *,−50.5% (−53.4 to −47.1) *
4,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,HIV/AIDS,NA,28300,26700,30200,26100,24300,28000,54400,51200,57700,0.02176,−44.8% (−46.6 to −42.5) *,−53.9% (−55.8 to −51.6) *,−49.6% (−51.3 to −47.4) *,724.0 (683.0 to 771.1),686.1 (638.2 to 735.8),704.8 (662.6 to 747.9),−51.1% (−52.6 to −49.0) *,−58.8% (−60.6 to −56.8) *,−55.2% (−56.8 to −53.3) *
5,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,HIV/AIDS,HIV/AIDS and drug-susceptible tuberculosis co-infection,5810,4180,7430,5260,3760,6760,11100,7940,14200,0.00444,−51.9% (−55.0 to −48.0) *,−57.8% (−60.8 to −53.9) *,−54.9% (−57.9 to −51.0) *,150.0 (108.3 to 191.6),140.2 (100.6 to 179.4),145.1 (104.4 to 185.3),−57.2% (−59.9 to −53.7) *,−62.3% (−65.0 to −58.9) *,−59.8% (−62.5 to −56.3) *
6,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,HIV/AIDS,HIV/AIDS and multidrug-resistant tuberculosis without extensive drug resistance co-infection,674,405,1020,589,347,905,1260,755,1920,5.04e-4,−48.9% (−62.9 to −29.4) *,−54.2% (−68.1 to −36.0) *,−51.5% (−65.6 to −32.9) *,17.4 (10.5 to 26.5),15.8 (9.3 to 24.2),16.6 (9.9 to 25.3),−54.4% (−67.0 to −37.1) *,−58.9% (−71.4 to −42.4) *,−56.6% (−69.1 to −40.1) *
7,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,HIV/AIDS,HIV/AIDS and extensively drug-resistant tuberculosis co-infection,39.3,23.8,58,23.9,14.9,35.3,63.3,38.8,93.3,2.5319999999999998e-5,−8.1% (−25.0 to 13.5),−13.5% (−32.8 to 10.9),−10.2% (−28.3 to 11.9),1.0 (0.6 to 1.5),0.6 (0.4 to 0.9),0.8 (0.5 to 1.2),−19.0% (−33.9 to −0.1) *,−23.3% (−40.4 to −1.7) *,−20.7% (−36.7 to −1.1) *
8,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,HIV/AIDS,HIV/AIDS resulting in other diseases,21800,19500,24300,20200,18000,22600,42100,37800,46700,0.01684,−42.4% (−45.1 to −39.2) *,−52.8% (−55.5 to −49.8) *,−47.9% (−50.5 to −44.9) *,555.5 (497.5 to 618.1),529.5 (469.3 to 591.4),542.3 (487.0 to 603.1),−49.0% (−51.3 to −46.1) *,−57.8% (−60.2 to −55.2) *,−53.7% (−56.1 to −51.1) *
9,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,Sexually transmitted infections excluding HIV,NA,6740,2970,12200,4730,2350,8070,11500,5320,20200,0.0046,−10.4% (−18.2 to −1.8) *,−6.8% (−14.2 to 1.2),−8.9% (−16.1 to −1.0) *,194.3 (84.5 to 355),142.1 (67.7 to 246.7),169.3 (76.7 to 300.4),−13.8% (−21.2 to −5.7) *,−11.7% (−18.4 to −4.7) *,−13.0% (−20.1 to −5.5) *
10,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,Sexually transmitted infections excluding HIV,Syphilis,6160,2430,11600,3750,1460,7060,9910,3930,18700,0.003964,−11.9% (−19.7 to −2.9) *,−10.4% (−18.5 to −1.7) *,−11.3% (−19.1 to −2.9) *,179.6 (70.8 to 339),117.3 (45.6 to 221.1),149.5 (59.1 to 283.2),−14.8% (−22.3 to −6.1) *,−13.4% (−21.2 to −5.0) *,−14.3% (−21.8 to −6.2) *
11,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,Sexually transmitted infections excluding HIV,Chlamydial infection,192,112,336,163,107,266,355,219,606,1.42e-4,7.9% (4.0 to 11.6) *,8.3% (4.8 to 11.3) *,8.1% (5.1 to 10.5) *,4.8 (2.8 to 8.5),4.1 (2.7 to 6.8),4.5 (2.8 to 7.7),−2.6% (−5.9 to 0.7),−3.5% (−7.0 to −0.9) *,−3.0% (−5.9 to −0.8) *
12,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,Sexually transmitted infections excluding HIV,Gonococcal infection,135,77.5,244,168,132,229,303,216,468,1.212e-4,11.2% (7.2 to 16.0) *,−0.3% (−5.7 to 5.5),4.5% (0.1 to 8.6) *,3.5 (2.0 to 6.2),4.2 (3.3 to 5.8),3.9 (2.7 to 6.0),2.2% (−1.5 to 6.5),−12.0% (−17.4 to −6.2) *,−6.1% (−10.7 to −2.1) *
13,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,Sexually transmitted infections excluding HIV,Trichomoniasis,7.04,2.77,14.8,236,94.7,508,243,97.6,524,9.72e-5,16.2% (12.8 to 19.5) *,16.0% (14.2 to 17.7) *,16.0% (14.2 to 17.7) *,0.2 (0.1 to 0.4),6.0 (2.4 to 12.9),3.1 (1.2 to 6.6),1.7% (−1.0 to 4.3),2.3% (1.2 to 3.4) *,2.2% (1.1 to 3.2) *
14,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,Sexually transmitted infections excluding HIV,Genital herpes,98.4,32,235,149,48,357,247,79.8,594,9.88e-5,21.2% (19.3 to 22.5) *,18.9% (17.0 to 20.4) *,19.8% (18.1 to 21.0) *,2.5 (0.8 to 5.9),3.7 (1.2 to 8.8),3.1 (1.0 to 7.4),2.6% (1.7 to 3.5) *,0.9% (−0.1 to 1.9),1.5% (0.9 to 2.3) *
15,All causes,"Communicable, maternal, neonatal, and nutritional diseases",HIV/AIDS and Sexually transmitted infections,Sexually transmitted infections excluding HIV,Other sexually transmitted infections,147,86.7,258,269,189,399,416,276,659,1.664e-4,8.0% (5.3 to 11.1) *,8.2% (5.2 to 11.0) *,8.1% (5.9 to 10.1) *,3.7 (2.2 to 6.6),6.8 (4.8 to 10.2),5.3 (3.5 to 8.4),−1.0% (−3.5 to 1.7),−3.5% (−6.6 to −0.8) *,−2.6% (−5.0 to −0.7) *
16,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,NA,NA,88800,84000,94100,71100,66900,75600,160000,152000,168000,0.064,−22.1% (−25.2 to −18.5) *,−24.0% (−27.4 to −20.4) *,−22.9% (−25.6 to −19.9) *,2434.0 (2298.0 to 2579.8),2002.9 (1881.7 to 2134.1),2209.6 (2095.9 to 2327.9),−30.7% (−33.5 to −27.5) *,−32.1% (−35.3 to −28.8) *,−31.4% (−33.9 to −28.6) *
17,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,Tuberculosis,NA,28000,26400,29700,17000,16100,18200,45000,42800,47300,0.018,−19.1% (−23.4 to −15.2) *,−20.6% (−24.6 to −13.1) *,−19.7% (−22.7 to −16.0) *,714.5 (672.6 to 759.4),437.3 (412.6 to 467.3),572.8 (544.0 to 602.4),−32.0% (−35.5 to −28.7) *,−32.2% (−35.5 to −25.8) *,−32.0% (−34.5 to −28.9) *
18,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,Tuberculosis,Latent tuberculosis infection,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,0 (0 to 0),0 (0 to 0),0 (0 to 0),NA,NA,NA
19,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,Tuberculosis,Drug-susceptible tuberculosis,24800,22600,26900,15100,13700,16500,39900,36400,43100,0.01596,−19.4% (−25.7 to −13.5) *,−21.4% (−28.2 to −13.0) *,−20.2% (−26.0 to −14.4) *,632.9 (576.3 to 686.5),389.1 (354.0 to 424.5),508.2 (463.4 to 548.7),−32.2% (−37.4 to −27.4) *,−32.9% (−38.4 to −25.6) *,−32.4% (−37.2 to −27.6) *
20,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,Tuberculosis,Multidrug-resistant tuberculosis without extensive drug resistance,2910,1710,4530,1740,971,2780,4650,2660,7220,0.0018600000000000001,−18.3% (−49.4 to 25.3),−15.0% (−49.6 to 33.5),−17.1% (−49.1 to 27.5),74.0 (43.5 to 115.1),44.6 (25.3 to 70.5),59.0 (34.0 to 91.4),−31.3% (−57.4 to 4.8),−27.3% (−56.5 to 13.6),−29.8% (−56.6 to 7.6)
21,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,Tuberculosis,Extensively drug-resistant tuberculosis,304,219,416,143,92.7,211,447,311,626,1.788e-4,2.0% (−23.9 to 38.3),15.8% (−20.7 to 69.3),6.0% (−22.7 to 45.8),7.7 (5.5 to 10.5),3.6 (2.3 to 5.3),5.6 (3.9 to 7.8),−14.4% (−36.2 to 16.1),−1.6% (−32.3 to 43.4),−10.7% (−34.8 to 22.8)
22,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,Lower respiratory infections,NA,56600,52800,60400,49900,46600,53000,106000,100000,112000,0.0424,−24.9% (−29.1 to −20.4) *,−26.8% (−30.7 to −22.6) *,−25.8% (−29.1 to −22.1) *,1605.9 (1498.2 to 1716.6),1453.6 (1354.5 to 1547.7),1523.9 (1433 to 1610.4),−31.4% (−35.3 to −27.4) *,−33.6% (−37.3 to −29.7) *,−32.5% (−35.6 to −29.1) *
23,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,Upper respiratory infections,NA,3200,1930,4960,3140,1910,4880,6340,3870,9820,0.002536,5.5% (−1.7 to 10.4),6.8% (0.7 to 10.7) *,6.1% (0.7 to 9.9) *,84.5 (51.1 to 131.1),84.7 (51.4 to 131.0),84.6 (51.7 to 130.7),−5.2% (−11.5 to −0.8) *,−4.2% (−9.5 to −0.5) *,−4.7% (−9.7 to −1.4) *
24,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Respiratory infections and tuberculosis,Otitis media,NA,1090,668,1730,992,608,1560,2080,1280,3290,8.32e-4,1.7% (−2.9 to 5.5),2.3% (−2.2 to 5.9),2.0% (−1.6 to 4.8),29.1 (17.8 to 46.2),27.3 (16.7 to 43.2),28.2 (17.3 to 44.7),−6.9% (−11.1 to −3.5) *,−6.8% (−10.9 to −3.6) *,−6.8% (−10.2 to −4.4) *
25,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Enteric infections,NA,NA,49100,41400,61500,46100,38700,57600,95200,83900,112000,0.03808,−27.0% (−35.6 to −16.6) *,−27.0% (−33.1 to −18.7) *,−27.0% (−32.5 to −20.5) *,1377.7 (1165.5 to 1708.6),1319.4 (1127.4 to 1605.6),1350.2 (1195.2 to 1579.1),−33.2% (−40.8 to −23.6) *,−34.3% (−39.8 to −27.0) *,−33.6% (−38.7 to −27.9) *
26,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Enteric infections,Diarrhoeal diseases,NA,41400,33900,53400,39600,32100,50200,81000,70100,97200,0.0324,−27.7% (−37.5 to −15.6) *,−27.8% (−35.0 to −18.1) *,−27.8% (−33.8 to −20.3) *,1166.8 (958.5 to 1491.2),1128.4 (932.6 to 1406.7),1149 (1005.2 to 1359.9),−34.0% (−42.8 to −22.8) *,−35.5% (−41.8 to −27.1) *,−34.7% (−40.1 to −28.1) *
27,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Enteric infections,Typhoid and paratyphoid,NA,5350,3070,8560,4450,2530,7300,9800,5580,15800,0.00392,−25.4% (−30.4 to −20.8) *,−21.9% (−27.7 to −17.0) *,−23.8% (−29.3 to −19.4) *,146.6 (84.1 to 235.4),128.8 (72.5 to 211.4),137.9 (78.4 to 223.3),−30.0% (−35.0 to −25.6) *,−27.0% (−32.6 to −22.3) *,−28.7% (−33.9 to −24.4) *
28,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Enteric infections,Typhoid and paratyphoid,Typhoid fever,4620,2590,7330,3820,2140,6220,8440,4730,13500,0.003376,−26.6% (−32.2 to −21.9) *,−23.7% (−30.4 to −18.7) *,−25.3% (−31.0 to −20.8) *,126.6 (71.2 to 202.5),110.5 (61.9 to 180.5),118.8 (66.9 to 190.4),−31.2% (−36.6 to −26.5) *,−28.7% (−35.0 to −23.9) *,−30.1% (−35.6 to −25.8) *
29,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Enteric infections,Typhoid and paratyphoid,Paratyphoid fever,730,336,1400,633,287,1220,1360,633,2630,5.44e-4,−16.3% (−25.7 to −5.7) *,−9.3% (−20.3 to 2.5),−13.2% (−21.2 to −3.8) *,20.0 (9.1 to 38.3),18.3 (8.3 to 35.2),19.1 (8.9 to 36.7),−21.5% (−30.4 to −11.6) *,−15.1% (−25.6 to −3.8) *,−18.7% (−26.5 to −9.8) *
30,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Enteric infections,Invasive non-typhoidal salmonella disease,NA,2240,1240,3850,2020,1150,3500,4260,2380,7380,0.001704,−16.0% (−25.9 to −3.1) *,−18.5% (−27.7 to −8.1) *,−17.2% (−25.7 to −6.8) *,63.0 (34.9 to 108.8),60.3 (34.0 to 104.8),61.7 (34.7 to 107.6),−21.4% (−31.0 to −9.1) *,−23.8% (−32.6 to −13.9) *,−22.6% (−30.7 to −12.5) *
31,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Enteric infections,Other intestinal infectious diseases,NA,45.5,26.6,87.5,59.9,33.5,120,105,68.7,172,4.2e-5,−43.0% (−75.3 to 37.9),−44% (−77.7 to 38.8),−43.6% (−71.4 to 11.5),1.3 (0.7 to 2.5),1.8 (1.0 to 3.7),1.5 (1.0 to 2.5),−46.4% (−76.8 to 30.8),−47.3% (−79.2 to 32.5),−46.9% (−73.5 to 5.7)
32,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,NA,NA,33300,25900,43000,29000,22300,36900,62300,48600,79900,0.02492,−29.5% (−37.2 to −21.1) *,−30.0% (−38.0 to −21.3) *,−29.7% (−37.2 to −21.2) *,917.6 (710.8 to 1192.3),836.2 (636.3 to 1073.7),877.6 (679.5 to 1129.2),−35.2% (−42.5 to −27.4) *,−36.2% (−43.7 to −28.0) *,−35.7% (−42.7 to −27.7) *
33,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Malaria,NA,24000,16800,32800,21100,14800,28400,45000,31700,61000,0.018,−33.0% (−42.5 to −22.3) *,−35.4% (−44.9 to −25.4) *,−34.2% (−43.1 to −23.5) *,672.3 (468.6 to 924.1),626.4 (437.9 to 848.8),649.8 (457.1 to 878.7),−37.7% (−46.8 to −27.6) *,−40.2% (−49.2 to −30.7) *,−38.9% (−47.4 to −28.8) *
34,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Chagas disease,NA,138,125,156,94,84.1,107,232,210,261,9.28e-5,−3.6% (−8.8 to 4.6),−1.4% (−5.9 to 4.6),−2.8% (−6.8 to 4.1),3.6 (3.2 to 4.0),2.2 (2.0 to 2.6),2.9 (2.6 to 3.2),−24.0% (−28.1 to −17.7) *,−22.7% (−26.2 to −18.0) *,−23.4% (−26.6 to −18.0) *
35,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Leishmaniasis,NA,442,89.4,1700,332,109,1030,774,199,2720,3.096e-4,−55.4% (−68.9 to 28.3),−46.5% (−67.3 to 36.1),−52% (−68.2 to 32.5),11.9 (2.3 to 46.7),9.2 (2.8 to 29.6),10.6 (2.6 to 38.2),−59.0% (−71.0 to 12.7),−52.1% (−69.9 to 20.1),−56.3% (−70.6 to 16.5)
36,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Leishmaniasis,Visceral leishmaniasis,326,0.657,1570,184,0.355,878,511,1.02,2440,2.044e-4,−63.9% (−85.7 to −41.3) *,−63.8% (−81.6 to −36.5) *,−63.9% (−84.5 to −40.0) *,8.9 (0 to 43.3),5.4 (0 to 25.8),7.2 (0 to 34.7),−66.3% (−87.4 to −46.2) *,−66.1% (−83.1 to −41.3) *,−66.2% (−86.0 to −44.3) *
37,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Leishmaniasis,Cutaneous and mucocutaneous leishmaniasis,116,74.8,171,148,96.6,216,264,172,389,1.056e-4,30.5% (20.3 to 43.1) *,32.3% (22.0 to 45.5) *,31.5% (21.2 to 44.2) *,3.0 (1.9 to 4.4),3.8 (2.5 to 5.5),3.4 (2.2 to 5.0),14.4% (4.6 to 26.4) *,15.8% (5.8 to 28.1) *,15.3% (5.2 to 27.4) *
38,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,African trypanosomiasis,NA,41.5,7.46,160,37.5,7.06,142,79,15.4,287,3.16e-5,−80.7% (−95.9 to −22.4) *,−80.8% (−95.8 to −30.1) *,−80.7% (−95.6 to −27.3) *,1.1 (0.2 to 4.2),1.0 (0.2 to 3.8),1.1 (0.2 to 3.9),−82.3% (−96.3 to −30.8) *,−82.3% (−96.2 to −33.5) *,−82.3% (−95.9 to −33.4) *
39,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Schistosomiasis,NA,693,427,1180,738,447,1250,1430,876,2440,5.72e-4,−19.3% (−21.9 to −15.7) *,−19.8% (−22.5 to −17.1) *,−19.6% (−21.6 to −17.3) *,17.7 (10.9 to 30.0),18.9 (11.5 to 31.9),18.3 (11.2 to 30.9),−29.3% (−31.8 to −26.2) *,−29.5% (−32.1 to −27.1) *,−29.4% (−31.4 to −27.4) *
40,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Cysticercosis,NA,671,440,928,937,618,1300,1610,1050,2230,6.44e-4,3.7% (−1.7 to 8.8),10.5% (5.5 to 15.1) *,7.6% (2.4 to 12.0) *,17.1 (11.2 to 23.5),23.1 (15.2 to 32.1),20.1 (13.2 to 27.8),−13.0% (−17.5 to −8.9) *,−7.3% (−11.7 to −3.5) *,−9.8% (−14.0 to −6.1) *
41,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Cystic echinococcosis,NA,46.8,32,65,53.4,37.2,73.4,100,72.8,139,4e-5,−22.7% (−46.2 to 7.7),−17.7% (−39 to 7.2),−20.1% (−36.7 to 0.6),1.2 (0.8 to 1.7),1.4 (1.0 to 1.9),1.3 (1.0 to 1.8),−32.5% (−53.1 to −6.3) *,−29.4% (−48.1 to −7.5) *,−30.8% (−45.2 to −13.2) *
42,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Lymphatic filariasis,NA,1110,569,1830,258,151,394,1360,752,2160,5.44e-4,−40.8% (−52.3 to −30.0) *,−13.2% (−16.7 to −9.8) *,−37.0% (−48.7 to −26.4) *,28.1 (14.4 to 46.4),6.6 (3.9 to 10.0),17.4 (9.6 to 27.5),−48.1% (−58.2 to −38.6) *,−24.2% (−27.5 to −21.2) *,−44.8% (−54.7 to −35.5) *
43,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Onchocerciasis,NA,719,346,1270,624,299,1130,1340,639,2370,5.36e-4,3.2% (−15.4 to 19.2),4.7% (−16.0 to 21.7),3.9% (−15.1 to 19.9),18.5 (8.9 to 32.7),16.2 (7.6 to 29.3),17.3 (8.2 to 30.5),−8.6% (−26.0 to 6.0),−7.3% (−26.6 to 8.3),−8.0% (−25.8 to 6.7)
44,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Trachoma,NA,122,80.3,174,181,120,253,303,202,425,1.212e-4,−0.7% (−11.7 to 10.5),−8.5% (−16.5 to −0.8) *,−5.5% (−13.1 to 2.0),3.4 (2.2 to 4.8),4.2 (2.8 to 5.9),3.8 (2.6 to 5.4),−25.6% (−33.6 to −17.3) *,−30.1% (−35.9 to −24.1) *,−28.2% (−33.8 to −22.5) *
45,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Dengue,NA,1530,754,2110,1390,651,1930,2920,1630,3970,0.001168,39.9% (4.2 to 73.1) *,42.1% (4 to 79.5) *,40.9% (13.9 to 67.9) *,41.1 (20.2 to 56.2),38 (17.6 to 52.8),39.6 (22.0 to 53.3),26.1% (−6.1 to 56.2),26.3% (−8.0 to 60.3),26.2% (2.2 to 49.5) *
46,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Yellow fever,NA,222,45.9,632,92.3,18.7,267,314,67.2,900,1.256e-4,−16.9% (−33.2 to 4.4),−13.5% (−31.2 to 8.6),−16.0% (−28.9 to 0) *,6.0 (1.2 to 17.0),2.6 (0.5 to 7.6),4.3 (0.9 to 12.4),−22.3% (−37.9 to −1.8) *,−19.1% (−35.6 to 2.3),−21.3% (−33.6 to −5.9) *
47,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Rabies,NA,441,356,598,193,98,287,634,504,836,2.536e-4,−49.9% (−60.1 to −33.9) *,−54.8% (−70.4 to −34.7) *,−51.5% (−61.3 to −38.9) *,11.7 (9.4 to 16.1),5.3 (2.7 to 8.1),8.6 (6.8 to 11.5),−54.4% (−63.8 to −39.4) *,−59.5% (−73.7 to −40.8) *,−56.2% (−65.1 to −44.3) *
48,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Intestinal nematode infections,NA,907,569,1410,1010,632,1560,1920,1200,2980,7.68e-4,−32.4% (−38.3 to −27.2) *,−32.2% (−37.8 to −26.9) *,−32.3% (−37.1 to −27.7) *,24.2 (15.3 to 37.5),27.8 (17.5 to 42.6),25.9 (16.4 to 40.1),−38.3% (−43.7 to −33.3) *,−38.2% (−43.6 to −33.2) *,−38.3% (−42.7 to −33.9) *
49,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Intestinal nematode infections,Ascariasis,427,284,641,434,284,661,861,569,1290,3.444e-4,−37.8% (−46.7 to −28.4) *,−37.2% (−46.2 to −27.1) *,−37.5% (−45.0 to −29.7) *,11.6 (7.7 to 17.3),12.3 (8.1 to 18.6),12.0 (8.0 to 17.8),−42.7% (−51.0 to −33.7) *,−42.4% (−50.9 to −32.6) *,−42.6% (−49.5 to −35.3) *
50,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Intestinal nematode infections,Trichuriasis,107,59.8,178,106,59.6,177,213,120,354,8.52e-5,−23.1% (−29.4 to −16.0) *,−23.0% (−29.3 to −15.7) *,−23.1% (−29.3 to −15.8) *,2.8 (1.6 to 4.6),2.8 (1.6 to 4.7),2.8 (1.6 to 4.7),−29.3% (−35.1 to −22.7) *,−29.2% (−35.0 to −22.5) *,−29.3% (−35.0 to −22.5) *
51,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Intestinal nematode infections,Hookworm disease,373,218,603,472,289,740,845,510,1340,3.38e-4,−27.8% (−33.3 to −22.0) *,−28.9% (−34.6 to −23.2) *,−28.5% (−34.0 to −22.7) *,9.8 (5.7 to 15.8),12.6 (7.7 to 19.8),11.2 (6.7 to 17.8),−34.7% (−39.7 to −29.3) *,−35.5% (−40.6 to −30.3) *,−35.2% (−40.2 to −30.0) *
52,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Food-borne trematodiases,NA,1110,627,1890,763,432,1280,1870,1070,3150,7.48e-4,4.3% (0.9 to 8.0) *,15.0% (9.8 to 20.2) *,8.5% (4.8 to 12.0) *,27.7 (15.7 to 47.1),19 (10.7 to 31.9),23.4 (13.4 to 39.3),−9.4% (−12.4 to −6.5) *,−1.0% (−5.3 to 3.2),−6.2% (−9.1 to −3.5) *
53,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Leprosy,NA,22.1,15,31,9.46,6.35,13.3,31.5,21.5,44.6,1.26e-5,−2.2% (−5.2 to 0.8),1.0% (−2.7 to 4.8),−1.3% (−3.7 to 1.1),0.6 (0.4 to 0.8),0.2 (0.2 to 0.3),0.4 (0.3 to 0.6),−21.2% (−23.6 to −18.9) *,−18.8% (−21.9 to −15.9) *,−20.4% (−22.4 to −18.5) *
54,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Ebola virus disease,NA,0.319,0.238,0.361,0.184,0.161,0.21,0.503,0.459,0.552,2.012e-7,−97.5% (−97.8 to −97.2) *,−98.6% (−98.8 to −98.4) *,−98.1% (−98.3 to −97.9) *,0 (0 to 0),0 (0 to 0),0 (0 to 0),−97.7% (−98.0 to −97.4) *,−98.7% (−98.9 to −98.5) *,−98.2% (−98.4 to −98.0) *
55,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Zika virus disease,NA,1.13,0.657,2.09,1.12,0.529,2.71,2.24,1.27,4.66,8.960000000000001e-7,NA,NA,NA,0 (0 to 0.1),0 (0 to 0.1),0 (0 to 0.1),NA,NA,NA
56,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Guinea worm disease,NA,2.49e-4,1.33e-4,3.98e-4,3.01e-4,1.61e-4,4.82e-4,5.5e-4,2.94e-4,8.83e-4,2.2000000000000002e-10,−99.5% (−99.7 to −99.3) *,−99.5% (−99.6 to −99.2) *,−99.5% (−99.6 to −99.3) *,0 (0 to 0),0 (0 to 0),0 (0 to 0),−99.6% (−99.7 to −99.4) *,−99.5% (−99.7 to −99.3) *,−99.5% (−99.7 to −99.3) *
57,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Neglected tropical diseases and malaria,Other neglected tropical diseases,NA,1130,743,2330,1200,794,2070,2340,1560,4190,9.36e-4,−2.6% (−13.5 to 9.7),−2.6% (−8.6 to 4.8),−2.6% (−9.5 to 5.6),31.6 (20.7 to 65.7),34.0 (22.5 to 60.8),32.8 (21.8 to 60.1),−9.7% (−20.1 to 1.9),−10.5% (−16.5 to −2.9) *,−10.1% (−16.7 to −2.3) *
58,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,NA,NA,29500,25200,34700,27500,23200,32600,57100,48800,67300,0.02284,−30.8% (−37.5 to −23.1) *,−32.1% (−38.7 to −24.3) *,−31.4% (−37.8 to −23.8) *,824.0 (703.3 to 971.5),810.9 (677.3 to 966.3),816.8 (693.8 to 970.0),−35.9% (−42.2 to −28.7) *,−37.3% (−43.5 to −29.9) *,−36.6% (−42.6 to −29.5) *
59,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Meningitis,NA,10900,9460,12700,9430,7810,11100,20400,17800,23400,0.00816,−23.3% (−31.0 to −12.2) *,−25.6% (−32.7 to −15.3) *,−24.4% (−30.6 to −15.3) *,306.8 (264.8 to 356.4),278.6 (232.0 to 327.4),293 (254.3 to 337.3),−28.4% (−35.6 to −17.9) *,−30.8% (−37.7 to −21.0) *,−29.6% (−35.5 to −21.1) *
60,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Meningitis,Pneumococcal meningitis,1770,1480,2130,1310,1080,1560,3080,2640,3600,0.001232,−18.5% (−27.9 to −4.6) *,−20.3% (−27.8 to −10.3) *,−19.2% (−26.5 to −8.9) *,49.4 (41.1 to 59.6),38.0 (31.3 to 45.3),43.9 (37.5 to 51.4),−24.2% (−33.1 to −11.3) *,−26.3% (−33.5 to −16.7) *,−25.1% (−32.1 to −15.1) *
61,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Meningitis,H influenzae type B meningitis,2530,2110,3140,2460,2070,3010,4990,4310,5890,0.001996,−39.5% (−46.2 to −31.0) *,−41.6% (−48 to −33.1) *,−40.6% (−46.1 to −33.3) *,70.9 (59.0 to 88.1),72.6 (60.7 to 88.6),71.6 (61.6 to 85),−43.8% (−50.0 to −35.6) *,−45.9% (−52.0 to −37.8) *,−44.9% (−50.1 to −38.0) *
62,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Meningitis,Meningococcal infection,1280,1050,1550,1000,819,1200,2280,1920,2720,9.12e-4,−33.5% (−41.4 to −22.0) *,−34.7% (−41.7 to −24.7) *,−34.0% (−40.3 to −25.6) *,36.2 (29.6 to 44.2),30.1 (24.3 to 36.1),33.2 (27.8 to 39.7),−37.5% (−45.0 to −26.4) *,−38.9% (−45.5 to −29.4) *,−38.1% (−44.1 to −30.0) *
63,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Meningitis,Other meningitis,5360,4570,6270,4660,3810,5480,10000,8600,11500,0.004,−10.5% (−19.7 to 3.3),−11.9% (−20.8 to 0.8),−11.1% (−18.5 to 0.6),150.4 (128.2 to 175.7),137.9 (112.6 to 162.9),144.2 (123.6 to 166.2),−16.3% (−25.1 to −3.1) *,−17.8% (−26.3 to −5.6) *,−17.0% (−24.2 to −5.9) *
64,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Encephalitis,NA,2620,2310,3030,2490,2220,2810,5110,4540,5760,0.002044,−12.4% (−27.6 to 4.5),−8.4% (−24.1 to 8.3),−10.5% (−25.5 to 4.7),71.6 (63.0 to 82.3),70.2 (62.0 to 79.2),70.8 (62.8 to 79.3),−20.4% (−34.4 to −5.1) *,−17.5% (−32.3 to −2.3) *,−18.9% (−32.9 to −5.2) *
65,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Diphtheria,NA,155,80.2,331,143,74.1,291,299,182,510,1.196e-4,−21.9% (−63.8 to 75.5),−26.1% (−65.7 to 71.5),−23.9% (−56.7 to 38.7),4.4 (2.3 to 9.5),4.4 (2.3 to 8.9),4.4 (2.7 to 7.6),−26.3% (−66.2 to 66.6),−30.4% (−67.9 to 62.6),−28.3% (−59.5 to 31.4)
66,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Whooping cough,NA,3540,1790,6340,4440,2250,7740,7980,4020,14100,0.003192,−24.1% (−54.8 to 33.4),−22.5% (−54.3 to 35.1),−23.2% (−54.5 to 35.0),102.5 (51.9 to 183.6),137.4 (69.6 to 239.7),119.3 (60.1 to 210.7),−27.7% (−56.9 to 27.1),−26.4% (−56.6 to 28.3),−27.0% (−56.8 to 28.4)
67,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Tetanus,NA,1400,955,1930,1050,753,1410,2450,1740,3200,9.8e-4,−58.1% (−70.2 to −37.9) *,−60.9% (−72.2 to −42.0) *,−59.3% (−69.9 to −43.5) *,38.9 (26.6 to 54.3),31.3 (22.5 to 42.2),35.2 (25 to 46.4),−61.0% (−72.2 to −42) *,−63.4% (−74.1 to −45.6) *,−62.1% (−72.1 to −47) *
68,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Measles,NA,4080,1460,8860,4080,1480,8710,8160,2950,17600,0.003264,−56.5% (−61.9 to −50.6) *,−57.2% (−62.6 to −51.6) *,−56.8% (−61.8 to −51.7) *,117.7 (42.1 to 255.6),125.6 (45.7 to 268.5),121.5 (44.0 to 261.7),−58.8% (−63.9 to −53.2) *,−59.5% (−64.7 to −54.2) *,−59.1% (−63.8 to −54.3) *
69,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Varicella and herpes zoster,NA,559,476,656,586,495,690,1140,985,1320,4.56e-4,−15.8% (−25.9 to −4.3) *,−12.3% (−23.2 to −1.6) *,−14.0% (−22.4 to −5.6) *,15.5 (13.3 to 18.1),16.5 (14.0 to 19.3),16.0 (13.9 to 18.4),−24.1% (−33.0 to −13.7) *,−21.6% (−31.6 to −11.5) *,−22.8% (−30.2 to −15.5) *
70,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Acute hepatitis,NA,3240,2150,3940,2750,1970,3390,5990,4580,6900,0.002396,−18.9% (−25.9 to −5.0) *,−21.0% (−29.2 to −12.3) *,−19.8% (−25.6 to −12.7) *,84.2 (55.8 to 102.9),74.2 (52.5 to 92.2),78.9 (60.1 to 91.2),−29.0% (−35.1 to −16) *,−30.1% (−37.5 to −22.4) *,−29.5% (−34.8 to −23.1) *
71,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Acute hepatitis,Acute hepatitis A,697,465,949,801,565,1050,1500,1130,1870,6e-4,−31.6% (−42.8 to −10.4) *,−32.7% (−44.1 to −19.5) *,−32.2% (−40.9 to −21.1) *,18.8 (12.6 to 25.4),23.1 (16.3 to 30.4),20.9 (15.7 to 26.2),−36.9% (−47.4 to −16.2) *,−37.5% (−48.6 to −24.5) *,−37.2% (−45.5 to −26.3) *
72,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Acute hepatitis,Acute hepatitis B,2050,1370,2460,1470,1040,1810,3530,2620,4120,0.001412,−11.2% (−20.0 to 1.6),−10.5% (−21.0 to 1.4),−10.9% (−18.2 to −2.0) *,52.4 (34.8 to 63.0),38.0 (26.7 to 46.7),45.1 (33.3 to 53.0),−24.7% (−32.1 to −13.9) *,−24.0% (−33.0 to −13.7) *,−24.5% (−30.4 to −17.0) *
73,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Acute hepatitis,Acute hepatitis C,106,54,187,122,64.9,207,228,124,383,9.12e-5,−30.5% (−44.8 to −1.8) *,−29.9% (−44.3 to −9.9) *,−30.2% (−42.2 to −14.7) *,3.0 (1.5 to 5.3),3.7 (1.9 to 6.2),3.3 (1.8 to 5.6),−35.1% (−48.3 to −7.0) *,−34.6% (−48.4 to −15.3) *,−34.8% (−46.4 to −20.3) *
74,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Acute hepatitis,Acute hepatitis E,382,226,507,356,247,459,739,517,935,2.956e-4,−24.5% (−36.5 to −10.1) *,−24.6% (−38.9 to −9.6) *,−24.6% (−34.1 to −13.6) *,9.9 (5.9 to 13.1),9.5 (6.6 to 12.3),9.7 (6.8 to 12.2),−31.2% (−41.6 to −18.4) *,−30.9% (−43.9 to −17.5) *,−31.1% (−39.5 to −21.2) *
75,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Other infectious diseases,Other unspecified infectious diseases,NA,2990,2240,3420,2580,1980,3060,5570,4300,6430,0.002228,−6.3% (−13.2 to 4.5),−10.5% (−15.7 to −5.8) *,−8.3% (−13.2 to −2.7) *,82.5 (61.4 to 94.3),72.7 (55.3 to 85.8),77.6 (59.3 to 89.5),−14.1% (−20.6 to −4.3) *,−18.8% (−23.7 to −14.4) *,−16.4% (−21 to −11.2) *
76,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,NA,NA,103000,97100,109000,94500,89300,100000,198000,187000,209000,0.0792,−20.1% (−23.3 to −16.5) *,−19.0% (−22.1 to −15.9) *,−19.6% (−22.5 to −16.5) *,2979.1 (2808.2 to 3151.8),2839.4 (2691.4 to 3000.0),2916.4 (2761.0 to 3077.1),−22.9% (−26.1 to −19.4) *,−22.9% (−25.8 to −19.8) *,−22.9% (−25.8 to −19.9) *
77,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,NA,NA,NA,NA,11800,11000,12800,11800,11000,12800,0.00472,NA,−24.1% (−28.3 to −19.9) *,−24.1% (−28.3 to −19.9) *,NA,305.5 (284.3 to 330.6),151.2 (140.7 to 163.6),NA,−30.3% (−34.1 to −26.3) *,−30.5% (−34.3 to −26.5) *
78,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Maternal haemorrhage,NA,NA,NA,2230,1910,2610,2230,1910,2610,8.92e-4,NA,−52.4% (−59.5 to −44.3) *,−52.4% (−59.5 to −44.3) *,NA,57.8 (49.6 to 67.4),28.6 (24.5 to 33.4),NA,−56.3% (−62.8 to −48.9) *,−56.4% (−62.8 to −49.1) *
79,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Maternal sepsis and other pregnancy-related infections,NA,NA,NA,1250,1080,1480,1250,1080,1480,5e-4,NA,−27.8% (−39.6 to −15.1) *,−27.8% (−39.6 to −15.1) *,NA,32.5 (27.8 to 38.4),16.1 (13.8 to 19.0),NA,−33.4% (−43.7 to −21.8) *,−33.6% (−43.9 to −21.9) *
80,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Maternal hypertensive disorders,NA,NA,NA,1870,1620,2190,1870,1620,2190,7.48e-4,NA,−6.2% (−21.4 to 9.8),−6.2% (−21.4 to 9.8),NA,48.9 (42.2 to 57.1),24.2 (20.9 to 28.2),NA,−13.0% (−27.2 to 1.9),−13.3% (−27.5 to 1.6)
81,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Maternal obstructed labour and uterine rupture,NA,NA,NA,1120,901,1380,1120,901,1380,4.48e-4,NA,−16.1% (−29.9 to −2.6) *,−16.1% (−29.9 to −2.6) *,NA,28.8 (23.2 to 35.6),14.3 (11.5 to 17.6),NA,−23.7% (−36.1 to −11.2) *,−23.9% (−36.3 to −11.5) *
82,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Maternal abortive outcome,NA,NA,NA,982,827,1180,982,827,1180,3.928e-4,NA,−8.7% (−23.9 to 8.8),−8.7% (−23.9 to 8.8),NA,25.3 (21.3 to 30.5),12.5 (10.5 to 15.1),NA,−16.4% (−30.2 to −0.5) *,−16.6% (−30.3 to −0.7) *
83,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Ectopic pregnancy,NA,NA,NA,606,424,896,606,424,896,2.424e-4,NA,−12.8% (−42.8 to 26.4),−12.8% (−42.8 to 26.4),NA,15.7 (11.0 to 23.4),7.8 (5.4 to 11.6),NA,−19.6% (−46.9 to 17.3),−19.8% (−47.1 to 16.9)
84,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Indirect maternal deaths,NA,NA,NA,1930,1690,2220,1930,1690,2220,7.72e-4,NA,−6.1% (−19.2 to 6.8),−6.1% (−19.2 to 6.8),NA,50.1 (43.9 to 57.5),24.8 (21.7 to 28.5),NA,−13.6% (−25.5 to −2.0) *,−13.9% (−25.8 to −2.3) *
85,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Late maternal deaths,NA,NA,NA,195,152,251,195,152,251,7.8e-5,NA,−2.0% (−8.2 to 4.1),−2.0% (−8.2 to 4.1),NA,5.1 (4.0 to 6.5),2.5 (2.0 to 3.2),NA,−9.8% (−15.1 to −4.3) *,−10.1% (−15.4 to −4.5) *
86,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Maternal deaths aggravated by HIV/AIDS,NA,NA,NA,84.4,53,114,84.4,53,114,3.376e-5,NA,−26.7% (−33.6 to −19.2) *,−26.7% (−33.6 to −19.2) *,NA,2.2 (1.4 to 2.9),1.1 (0.7 to 1.4),NA,−34.1% (−40.4 to −27.3) *,−34.2% (−40.6 to −27.5) *
87,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Maternal disorders,Other maternal disorders,NA,NA,NA,1520,1280,1810,1520,1280,1810,6.08e-4,NA,−8.0% (−24.7 to 10.9),−8.0% (−24.7 to 10.9),NA,39.2 (33.0 to 46.7),19.4 (16.4 to 23.1),NA,−15.5% (−30.5 to 1.5),−15.7% (−30.7 to 1.3)
88,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Neonatal disorders,NA,103000,97100,109000,82700,77800,88200,186000,175000,197000,0.0744,−20.1% (−23.3 to −16.5) *,−18.2% (−21.7 to −14.6) *,−19.3% (−22.4 to −15.9) *,2979.1 (2808.2 to 3151.8),2533.9 (2389.9 to 2691.1),2765.2 (2611.8 to 2922.7),−22.9% (−26.1 to −19.4) *,−21.9% (−25.2 to −18.4) *,−22.5% (−25.5 to −19.2) *
89,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Neonatal disorders,Neonatal preterm birth,38400,35200,42800,31800,28500,36000,70200,64400,77200,0.02808,−20.9% (−26.6 to −15.1) *,−18.7% (−24.7 to −12.4) *,−19.9% (−25.3 to −14.4) *,1109.6 (1019.0 to 1236.1),966.4 (871.4 to 1090.2),1041.2 (958.9 to 1138.5),−23.8% (−29.2 to −18.3) *,−22.7% (−28.4 to −17.0) *,−23.3% (−28.4 to −18.3) *
90,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Neonatal disorders,Neonatal encephalopathy due to birth asphyxia and trauma,32200,28300,36200,24300,21200,27700,56500,50200,63100,0.0226,−19.7% (−27.1 to −11.6) *,−18.4% (−25.6 to −11.3) *,−19.1% (−25.0 to −12.4) *,928.1 (817.0 to 1038.6),742.9 (644.7 to 836.9),838.9 (746.3 to 930.9),−22.7% (−29.8 to −14.9) *,−22.2% (−29.0 to −15.4) *,−22.5% (−28.0 to −16.4) *
91,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Neonatal disorders,Neonatal sepsis and other neonatal infections,11900,10100,14600,10100,7820,13700,22000,18900,28000,0.0088,−10.5% (−20.2 to 0.8),−3.2% (−14.6 to 7.0),−7.3% (−15.3 to 1.5),343.3 (291.8 to 416.1),306.1 (241.7 to 420.6),325.4 (281.2 to 417.5),−14.1% (−23.4 to −3.1) *,−7.8% (−18.9 to 1.8),−11.3% (−19.0 to −2.7) *
92,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Neonatal disorders,Haemolytic disease and other neonatal jaundice,2890,2480,3300,2300,1970,2660,5190,4610,5790,0.002076,−31.9% (−41.3 to −21.1) *,−32.1% (−42.3 to −18.4) *,−32.0% (−39.7 to −22.9) *,83.3 (71.5 to 95.2),70.4 (60.1 to 81.8),77.1 (68.4 to 86.0),−34.5% (−43.6 to −24.2) *,−35.3% (−45.1 to −21.8) *,−34.9% (−42.3 to −26.0) *
93,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Maternal and neonatal disorders,Neonatal disorders,Other neonatal disorders,17600,13900,19800,14300,12200,16000,31800,27100,34800,0.01272,−22.3% (−30.3 to −12.3) *,−23.0% (−31.3 to −13.2) *,−22.6% (−28.7 to −14.7) *,514.8 (407.8 to 579.1),448.2 (384.7 to 503.4),482.6 (410.4 to 527.5),−24.4% (−32.2 to −14.7) *,−25.3% (−33.3 to −15.8) *,−24.8% (−30.6 to −17.1) *
94,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Nutritional deficiencies,NA,NA,23600,17900,30700,34400,26000,45600,58000,44300,76900,0.0232,−21.1% (−27.5 to −14.0) *,−14.0% (−17.6 to −10.5) *,−17.0% (−21.4 to −12.6) *,655.9 (499.1 to 849.1),964.9 (731.6 to 1268.5),808.7 (619.2 to 1065.8),−27.3% (−33.2 to −20.8) *,−22.0% (−25.4 to −18.7) *,−24.3% (−28.3 to −20.3) *
95,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Nutritional deficiencies,Protein-energy malnutrition,NA,7770,6790,9010,8430,7490,9310,16200,14500,18000,0.00648,−36.5% (−43.9 to −22.8) *,−28.6% (−34.8 to −22.5) *,−32.7% (−38.3 to −24.7) *,222.6 (194.7 to 258.2),254.9 (225.6 to 281.7),238.0 (212.7 to 264.8),−40.7% (−47.6 to −27.8) *,−33.5% (−39.3 to −27.7) *,−37.2% (−42.5 to −29.7) *
96,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Nutritional deficiencies,Iodine deficiency,NA,886,542,1370,1170,705,1870,2060,1250,3260,8.24e-4,−6.9% (−10.6 to −4.0) *,−7.0% (−10.1 to −4.0) *,−6.9% (−10.1 to −4.3) *,22.8 (14.0 to 35.4),30.8 (18.5 to 48.9),26.7 (16.2 to 42.3),−17.6% (−20.8 to −14.9) *,−17.2% (−20.2 to −14.3) *,−17.4% (−20.1 to −14.9) *
97,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Nutritional deficiencies,Dietary iron deficiency,NA,10700,7040,15800,19300,13000,27800,30000,20300,43600,0.012,−5.6% (−11.3 to 0.3),−5.0% (−8.0 to −2.1) *,−5.2% (−8.3 to −1.9) *,291.9 (191.3 to 428.4),514.3 (345.7 to 740.8),403.0 (272.4 to 586.6),−13.7% (−18.8 to −8.1) *,−14.6% (−17.3 to −12.0) *,−14.3% (−17.2 to −11.4) *
98,All causes,"Communicable, maternal, neonatal, and nutritional diseases",Nutritional deficiencies,Other nutritional deficiencies,NA,561,479,693,885,751,1020,1450,1250,1640,5.8e-4,−32.3% (−40.1 to −14.3) *,−21.7% (−30.7 to −12.7) *,−26.2% (−33.4 to −17.7) *,15.3 (13.1 to 18.9),23.8 (20.0 to 27.7),19.5 (16.8 to 22.3),−40.7% (−47.5 to −25.0) *,−32.7% (−40.8 to −24.8) *,−35.9% (−42.3 to −28.5) *
99,All causes,Non-communicable diseases,NA,NA,NA,811000,732000,902000,740000,649000,844000,1550000,1380000,1750000,0.62,15.7% (14.5 to 16.9) *,16.4% (15.3 to 17.4) *,16.0% (15.1 to 16.9) *,21329.9 (19298.6 to 23679.8),18204.5 (15923.1 to 20796.3),19676.5 (17509.8 to 22177.9),−6.2% (−7.4 to −5.2) *,−5.0% (−6.1 to −4.1) *,−5.6% (−6.6 to −4.8) *
100,All causes,Non-communicable diseases,Neoplasms,NA,NA,131000,128000,135000,102000,99300,105000,234000,229000,238000,0.0936,20.2% (17.8 to 22.6) *,20.2% (17.2 to 23.1) *,20.2% (18.3 to 22.0) *,3417.7 (3337.7 to 3497.3),2454.6 (2386.7 to 2517.4),2900.9 (2842.8 to 2957),−5.7% (−7.6 to −3.9) *,−4.5% (−7.0 to −2.3) *,−5.1% (−6.6 to −3.7) *
101,All causes,Non-communicable diseases,Neoplasms,Lip and oral cavity cancer,NA,3490,3240,3680,1770,1660,1880,5250,4980,5500,0.0021,27.3% (18.3 to 34.2) *,38.4% (30.6 to 47.1) *,30.8% (24.1 to 36.6) *,87.6 (81.5 to 92.4),42.2 (39.6 to 45.0),64.2 (60.9 to 67.2),0.4% (−6.6 to 5.8),9.5% (3.3 to 16.5) *,3.2% (−2.0 to 7.7)
102,All causes,Non-communicable diseases,Neoplasms,Nasopharynx cancer,NA,1520,1440,1610,563,539,589,2090,2000,2170,8.36e-4,19.0% (13.2 to 25.4) *,16.9% (11.2 to 23.7) *,18.4% (14.0 to 23.1) *,38.0 (36.0 to 40.1),13.6 (13.0 to 14.2),25.4 (24.4 to 26.5),−4.7% (−9.2 to 0.4),−5.5% (−10.1 to −0.2) *,−4.9% (−8.5 to −1.2) *
103,All causes,Non-communicable diseases,Neoplasms,Other pharynx cancer,NA,2340,1940,2540,927,859,990,3260,2820,3460,0.001304,34.5% (20.6 to 47.1) *,40.2% (30.1 to 49.4) *,36.1% (25.6 to 44.3) *,58.2 (48.3 to 63.4),22.1 (20.4 to 23.6),39.6 (34.3 to 42.0),5.4% (−5.6 to 15.1),10.5% (2.4 to 17.8) *,6.6% (−1.6 to 12.9)
104,All causes,Non-communicable diseases,Neoplasms,Oesophageal cancer,NA,7190,6960,7420,2590,2480,2690,9780,9530,10000,0.003912,11.2% (7.2 to 15.2) *,3.4% (−1.7 to 8.3),9.0% (5.9 to 12.2) *,184.3 (178.3 to 190.1),61.0 (58.5 to 63.4),119.9 (116.9 to 123.0),−14.5% (−17.5 to −11.4) *,−20.3% (−24.2 to −16.6) *,−16.2% (−18.5 to −13.7) *
105,All causes,Non-communicable diseases,Neoplasms,Stomach cancer,NA,12200,11900,12600,6880,6680,7080,19100,18700,19600,0.00764,5.6% (2.4 to 9.2) *,4.5% (0.8 to 8.0) *,5.2% (2.8 to 7.8) *,317.8 (308.7 to 327.9),163.0 (158.3 to 167.8),235.9 (231.1 to 241.3),−18.5% (−20.9 to −15.8) *,−18.1% (−21.1 to −15.4) *,−18.4% (−20.2 to −16.3) *
106,All causes,Non-communicable diseases,Neoplasms,Colon and rectum cancer,NA,10700,10200,11000,8330,8060,8580,19000,18500,19500,0.0076,26.9% (20.9 to 31.5) *,21.6% (15.9 to 26.0) *,24.5% (20.0 to 28.3) *,280.3 (269 to 290.5),196.3 (189.9 to 202.2),235.7 (229.7 to 242.0),−2.6% (−7.1 to 0.8),−6.0% (−10.4 to −2.6) *,−4.1% (−7.5 to −1.2) *
107,All causes,Non-communicable diseases,Neoplasms,Liver cancer,NA,15200,14300,16300,5530,5320,5750,20800,19900,21800,0.00832,22.9% (16.8 to 31.8) *,17.6% (12.0 to 25.0) *,21.4% (17.3 to 27.5) *,382.9 (360.9 to 408.8),130.9 (125.9 to 136.2),253.6 (243.2 to 266.2),−3.0% (−7.7 to 4.0),−8.2% (−12.5 to −2.5) *,−4.5% (−7.8 to 0.2)
108,All causes,Non-communicable diseases,Neoplasms,Liver cancer,Liver cancer due to hepatitis B,7580,7030,8270,1970,1840,2110,9550,8920,10300,0.00382,16.4% (10.2 to 26.6) *,9.2% (2.6 to 17.3) *,14.9% (9.9 to 22.1) *,187.3 (173.8 to 204.4),47.0 (43.8 to 50.4),115.8 (108.3 to 124.4),−6.7% (−11.6 to 1.3),−13.1% (−18.4 to −6.7) *,−8.2% (−12.1 to −2.5) *
109,All causes,Non-communicable diseases,Neoplasms,Liver cancer,Liver cancer due to hepatitis C,3160,2880,3450,1800,1690,1910,4960,4600,5330,0.001984,29.5% (23.6 to 36.8) *,23.0% (18.0 to 29.5) *,27.1% (23.4 to 31.7) *,81.5 (74.7 to 88.7),42.1 (39.6 to 44.7),61.1 (56.9 to 65.6),−1.0% (−5.4 to 4.6),−6.1% (−9.9 to −1.1) *,−2.9% (−5.7 to 0.6)
110,All causes,Non-communicable diseases,Neoplasms,Liver cancer,Liver cancer due to alcohol use,2490,2160,2910,589,514,688,3080,2680,3590,0.001232,29.0% (22.0 to 36.7) *,23.6% (18.4 to 30.0) *,27.9% (22.5 to 34.0) *,63.2 (55.2 to 73.3),13.9 (12.1 to 16.2),37.6 (32.9 to 43.8),0.4% (−4.6 to 6.0),−4.2% (−8.2 to 0.7),−0.5% (−4.4 to 4.0)
111,All causes,Non-communicable diseases,Neoplasms,Liver cancer,Liver cancer due to NASH,956,842,1070,505,451,560,1460,1300,1620,5.84e-4,40.7% (33.5 to 49.8) *,31.6% (25.4 to 39.2) *,37.4% (32.8 to 42.9) *,24.6 (21.8 to 27.6),11.9 (10.6 to 13.2),18.0 (16.1 to 20.0),9.1% (3.7 to 16.1) *,1.6% (−3.1 to 7.3),6.4% (3.0 to 10.6) *
112,All causes,Non-communicable diseases,Neoplasms,Liver cancer,Liver cancer due to other causes,1050,930,1200,670,607,743,1720,1540,1920,6.88e-4,24.9% (17.6 to 34) *,16.0% (9.6 to 24.5) *,21.3% (16.2 to 27.7) *,26.3 (23.3 to 29.7),16.0 (14.5 to 17.7),21.1 (19.0 to 23.5),0.1% (−5.3 to 7.2),−8.1% (−13 to −1.5) *,−3.3% (−7.0 to 1.5)
113,All causes,Non-communicable diseases,Neoplasms,Gallbladder and biliary tract cancer,NA,1460,1220,1620,2020,1710,2160,3480,3040,3710,0.001392,21.9% (15.8 to 27.9) *,22.0% (16.7 to 27.2) *,22.0% (18.0 to 26.4) *,38.7 (32.2 to 42.9),47.5 (40.2 to 50.7),43.2 (37.7 to 46.1),−6.9% (−11.4 to −2.5) *,−6.4% (−10.5 to −2.4) *,−6.7% (−9.8 to −3.4) *
114,All causes,Non-communicable diseases,Neoplasms,Pancreatic cancer,NA,4990,4830,5140,4090,4000,4190,9080,8890,9260,0.003632,33.6% (28.1 to 38.1) *,38.6% (35.7 to 41.4) *,35.8% (32.5 to 38.6) *,129.4 (125.4 to 133.2),96.1 (94.0 to 98.4),112.2 (110.0 to 114.4),2.6% (−1.5 to 6.0),6.0% (3.8 to 8.1) *,4.0% (1.5 to 6.1) *
115,All causes,Non-communicable diseases,Neoplasms,Larynx cancer,NA,2730,2650,2820,547,523,570,3280,3190,3380,0.001312,16.9% (13.2 to 20.8) *,22.5% (17.1 to 28.0) *,17.8% (14.4 to 21.4) *,69.0 (66.9 to 71.1),13.0 (12.4 to 13.5),39.9 (38.8 to 41.0),−9.6% (−12.3 to −6.6) *,−4.0% (−8.2 to 0.3),−8.8% (−11.3 to −6) *
116,All causes,Non-communicable diseases,Neoplasms,"Tracheal, bronchus, and lung cancer",NA,28400,27500,29200,12600,12200,13000,40900,40000,41900,0.01636,22.3% (18.0 to 26.0) *,31.7% (27.5 to 35.9) *,25.0% (21.9 to 27.8) *,734.1 (712 to 754.8),295.7 (286.6 to 305.2),503.1 (491.9 to 514.3),−6.4% (−9.6 to −3.5) *,1.4% (−1.8 to 4.6),−4.0% (−6.4 to −1.9) *
117,All causes,Non-communicable diseases,Neoplasms,Malignant skin melanoma,NA,905,603,1130,749,584,966,1650,1330,1940,6.6e-4,17.3% (9.6 to 22.9) *,17.3% (11.1 to 25.5) *,17.3% (14.0 to 21.0) *,23.3 (15.4 to 28.9),17.9 (14.0 to 23.1),20.5 (16.5 to 24.0),−6.2% (−12.0 to −1.6) *,−6.2% (−11.0 to 0.8),−6.3% (−8.9 to −3) *
118,All causes,Non-communicable diseases,Neoplasms,Non-melanoma skin cancer,NA,929,883,976,400,380,426,1330,1270,1400,5.32e-4,28.4% (25.3 to 30.9) *,34.4% (27.7 to 40.1) *,30.1% (26.5 to 32.8) *,24.9 (23.6 to 26.2),9.4 (9.0 to 10.0),16.6 (15.9 to 17.5),−1.5% (−3.8 to 0.4),3.7% (−1.4 to 8.1),0.3% (−2.3 to 2.4)
119,All causes,Non-communicable diseases,Neoplasms,Non-melanoma skin cancer,Non-melanoma skin cancer (squamous-cell carcinoma),928,883,975,399,379,424,1330,1270,1390,5.32e-4,28.4% (25.3 to 30.9) *,34.5% (27.7 to 40.2) *,30.1% (26.5 to 32.8) *,24.8 (23.6 to 26.1),9.4 (8.9 to 10.0),16.6 (15.9 to 17.5),−1.5% (−3.8 to 0.4),3.7% (−1.4 to 8.1),0.3% (−2.3 to 2.4)
120,All causes,Non-communicable diseases,Neoplasms,Non-melanoma skin cancer,Non-melanoma skin cancer (basal-cell carcinoma),1.35,0.512,2.86,1.12,0.433,2.33,2.47,0.945,5.2,9.880000000000001e-7,32.6% (24.7 to 39.4) *,28.6% (20.0 to 35.8) *,30.8% (23.1 to 37.0) *,0 (0 to 0.1),0 (0 to 0.1),0 (0 to 0.1),−1.5% (−7.3 to 3.4),−1.5% (−7.6 to 3.5),−1.0% (−6.4 to 3.2)
121,All causes,Non-communicable diseases,Neoplasms,Breast cancer,NA,285,273,299,17400,16600,18400,17700,16900,18700,0.00708,39.0% (31.5 to 46.1) *,24.4% (17.8 to 29.1) *,24.6% (18.1 to 29.3) *,7.3 (7.0 to 7.6),414.7 (395.5 to 437.6),216.3 (206.4 to 228.1),7.9% (2.3 to 13.2) *,−1.4% (−6.5 to 2.4),−1.2% (−6.3 to 2.5)
122,All causes,Non-communicable diseases,Neoplasms,Cervical cancer,NA,NA,NA,NA,8060,7530,8400,8060,7530,8400,0.003224,NA,15.2% (9.5 to 19.2) *,15.2% (9.5 to 19.2) *,NA,193.0 (180.2 to 201.2),98.2 (91.7 to 102.4),NA,−7.1% (−11.8 to −3.9) *,−7.0% (−11.6 to −3.8) *
123,All causes,Non-communicable diseases,Neoplasms,Uterine cancer,NA,NA,NA,NA,2140,2060,2230,2140,2060,2230,8.56e-4,NA,16.6% (13.3 to 20.8) *,16.6% (13.3 to 20.8) *,NA,50.5 (48.5 to 52.5),26.3 (25.2 to 27.3),NA,−9.8% (−12.4 to −6.7) *,−9.8% (−12.4 to −6.7) *
124,All causes,Non-communicable diseases,Neoplasms,Ovarian cancer,NA,NA,NA,NA,4670,4530,4830,4670,4530,4830,0.001868,NA,29% (24.7 to 33.1) *,29.0% (24.7 to 33.1) *,NA,110.9 (107.5 to 114.6),57.1 (55.4 to 59.0),NA,1.3% (−2.0 to 4.5),1.2% (−2.1 to 4.3)
125,All causes,Non-communicable diseases,Neoplasms,Prostate cancer,NA,7060,6050,8350,NA,NA,NA,7060,6050,8350,0.002824,29.7% (26.3 to 36.3) *,NA,29.7% (26.3 to 36.3) *,201.3 (171.7 to 237.1),NA,90.0 (77.2 to 106.6),−4.4% (−6.8 to 0.6),NA,−2.6% (−5.1 to 2.4)
126,All causes,Non-communicable diseases,Neoplasms,Testicular cancer,NA,375,356,398,NA,NA,NA,375,356,398,1.5e-4,2.7% (−1.4 to 8.0),NA,2.7% (−1.4 to 8.0),9.5 (9.0 to 10.1),NA,4.7 (4.5 to 5.0),−9.4% (−13.0 to −4.7) *,NA,−9.2% (−12.9 to −4.5) *
127,All causes,Non-communicable diseases,Neoplasms,Kidney cancer,NA,2170,2030,2240,1120,1030,1160,3280,3090,3390,0.001312,25.3% (20.3 to 29.6) *,19.2% (11.8 to 25.7) *,23.2% (18.5 to 27.3) *,56.5 (53.0 to 58.5),27.2 (25.0 to 28.3),41.1 (38.7 to 42.5),−1.9% (−5.7 to 1.4),−5.7% (−11.5 to −0.3) *,−3.2% (−6.9 to 0.1)
128,All causes,Non-communicable diseases,Neoplasms,Bladder cancer,NA,2710,2600,2870,889,854,924,3600,3480,3770,0.00144,24.2% (21.1 to 27.3) *,20.6% (14.3 to 26.1) *,23.3% (20.6 to 26.0) *,74.2 (71.2 to 78.7),20.9 (20.1 to 21.7),45.3 (43.7 to 47.4),−6.5% (−8.8 to −4.2) *,−7.7% (−12.5 to −3.4) *,−6.4% (−8.4 to −4.3) *
129,All causes,Non-communicable diseases,Neoplasms,Brain and nervous system cancer,NA,5030,4200,5740,3720,2690,4210,8740,7650,9550,0.003496,24.2% (16.8 to 33.9) *,12.4% (−3.8 to 31.5),18.9% (12.3 to 25.1) *,129.4 (108.3 to 147.9),95.0 (68.6 to 107.9),111.9 (97.8 to 122.5),5.0% (−1.2 to 13.3),−5.3% (−19.1 to 11.1),0.4% (−5.3 to 5.7)
130,All causes,Non-communicable diseases,Neoplasms,Thyroid cancer,NA,468,444,493,665,618,747,1130,1070,1230,4.52e-4,30.3% (21.6 to 36.6) *,19.6% (12.6 to 27.0) *,23.8% (18.6 to 29.6) *,12.1 (11.5 to 12.7),16.0 (14.9 to 18.0),14.1 (13.3 to 15.3),3.7% (−3.1 to 8.6),−3.8% (−9.6 to 2.4),−0.9% (−5.1 to 3.8)
131,All causes,Non-communicable diseases,Neoplasms,Mesothelioma,NA,478,462,494,193,181,208,671,648,693,2.684e-4,23.0% (15.9 to 29.0) *,16.7% (7.0 to 25.5) *,21.1% (13.9 to 27.4) *,12.5 (12.1 to 12.9),4.6 (4.3 to 5.0),8.3 (8.0 to 8.6),−4.9% (−10.2 to −0.4) *,−7.0% (−14.2 to −0.6) *,−5.3% (−10.7 to −0.7) *
132,All causes,Non-communicable diseases,Neoplasms,Hodgkin lymphoma,NA,871,705,1090,508,400,606,1380,1160,1620,5.52e-4,−6.0% (−9.6 to −2.3) *,−1.8% (−7.7 to 4.4),−4.5% (−8.0 to −1.1) *,22.5 (18.1 to 28.2),13.1 (10.3 to 15.6),17.8 (14.9 to 20.9),−18.3% (−21.5 to −15.1) *,−13.1% (−18.4 to −7.1) *,−16.6% (−19.5 to −13.4) *
133,All causes,Non-communicable diseases,Neoplasms,Non-hodgkin lymphoma,NA,4260,4070,4420,2760,2670,2860,7020,6790,7230,0.002808,23.2% (12.7 to 28.8) *,21.5% (14.5 to 27.8) *,22.5% (16.2 to 27.3) *,111.1 (106.2 to 115.4),68.5 (66.1 to 71.2),89.3 (86.1 to 92.2),1.2% (−7.2 to 5.8),−0.7% (−6.6 to 4.7),0.4% (−4.9 to 4.6)
134,All causes,Non-communicable diseases,Neoplasms,Multiple myeloma,NA,1240,1090,1460,1080,1030,1240,2330,2180,2610,9.32e-4,32.4% (23.6 to 38.6) *,29.3% (23.9 to 34.6) *,30.9% (26.1 to 35.0) *,32.4 (28.2 to 37.9),25.5 (24.3 to 29.2),28.8 (26.9 to 32.2),1.7% (−4.8 to 6.3),−0.5% (−4.5 to 3.6),0.7% (−2.9 to 3.8)
135,All causes,Non-communicable diseases,Neoplasms,Leukaemia,NA,6820,6010,7300,5150,4420,5630,12000,10700,12800,0.0048,4.3% (0.4 to 9.0) *,0.6% (−8.4 to 6.0),2.7% (−3.3 to 6.6),181.0 (159.4 to 194.1),134.2 (115.0 to 147.3),156.8 (140.8 to 168.1),−10.4% (−13.9 to −6.5) *,−13.5% (−21.6 to −8.5) *,−11.7% (−17 to −8.3) *
136,All causes,Non-communicable diseases,Neoplasms,Leukaemia,Acute lymphoid leukaemia,1580,1360,1740,1130,923,1310,2700,2380,2990,0.00108,4.2% (−6.1 to 19.1),7.8% (−13.8 to 18.0),5.6% (−8.2 to 15.9),42.2 (36.2 to 46.7),31.1 (25.5 to 36.4),36.7 (32.2 to 40.7),−5.7% (−15.3 to 7.9),−2.3% (−22.5 to 7.4),−4.4% (−17.4 to 5.0)
137,All causes,Non-communicable diseases,Neoplasms,Leukaemia,Chronic lymphoid leukaemia,436,401,473,273,245,296,709,667,755,2.836e-4,20.5% (15.0 to 26.7) *,20.4% (15.9 to 24.7) *,20.5% (16.4 to 24.5) *,11.8 (10.9 to 12.8),6.5 (5.8 to 7.0),8.9 (8.4 to 9.5),−8.4% (−12.5 to −3.7) *,−7.1% (−10.6 to −3.7) *,−7.7% (−10.8 to −4.6) *
138,All causes,Non-communicable diseases,Neoplasms,Leukaemia,Acute myeloid leukaemia,1870,1590,2020,1350,1180,1520,3220,2890,3440,0.001288,20.5% (11.1 to 29.1) *,10.9% (−6.1 to 19.9),16.3% (4.5 to 24.6) *,49.2 (41.7 to 53.1),34.5 (30.0 to 39.1),41.7 (37.3 to 44.5),1.9% (−5.8 to 9.1),−5.9% (−20.6 to 2.1),−1.4% (−11.2 to 5.8)
139,All causes,Non-communicable diseases,Neoplasms,Leukaemia,Chronic myeloid leukaemia,347,309,383,308,259,358,655,595,713,2.62e-4,−1.8% (−6.1 to 3.1),−1.4% (−7.5 to 3.6),−1.6% (−5.0 to 1.7),9.0 (8.0 to 9.9),7.5 (6.3 to 8.7),8.2 (7.4 to 8.9),−20.3% (−23.7 to −16.4) *,−19.0% (−23.9 to −14.8) *,−19.6% (−22.4 to −17.0) *
140,All causes,Non-communicable diseases,Neoplasms,Leukaemia,Other leukaemia,2590,2190,2920,2090,1700,2320,4690,4040,5120,0.001876,−6.0% (−11.4 to 1.5),−9.7% (−19.9 to −2.4) *,−7.7% (−14.2 to −1.4) *,68.8 (58.1 to 77.3),54.6 (44.1 to 60.7),61.4 (53.0 to 67.0),−18.9% (−23.4 to −12.6) *,−22.3% (−31.4 to −15.8) *,−20.5% (−26.1 to −15.1) *
141,All causes,Non-communicable diseases,Neoplasms,Other malignant cancers,NA,6300,5620,6650,5570,5090,5960,11900,11000,12400,0.00476,21.1% (14.3 to 27.3) *,23.1% (17.0 to 28.8) *,22.0% (15.8 to 27.0) *,165.0 (147.5 to 174.4),142.4 (129.9 to 152.7),153.2 (142.0 to 160.8),2.0% (−3.7 to 7.1),3.7% (−1.8 to 9.0),2.7% (−2.5 to 7.0)
142,All causes,Non-communicable diseases,Neoplasms,Other neoplasms,NA,1290,963,1690,1190,926,1540,2480,2080,2980,9.92e-4,35.6% (23.6 to 50.5) *,30.2% (20.3 to 43.3) *,33.0% (26.1 to 42.4) *,34.5 (25.4 to 45.1),29.4 (23.1 to 38.1),31.8 (26.6 to 38.2),9.5% (−0.4 to 21.8),6.0% (−2.3 to 17.3),7.9% (2.1 to 16.2) *
143,All causes,Non-communicable diseases,Neoplasms,Other neoplasms,"Myelodysplastic, myeloproliferative, and other haemopoietic neoplasms",1180,876,1550,1060,823,1380,2240,1880,2720,8.96e-4,36.2% (23.8 to 51.8) *,31.3% (22.3 to 44.4) *,33.9% (26.8 to 43.1) *,31.6 (23.2 to 41.4),26.0 (20.3 to 33.8),28.6 (23.9 to 34.6),8.7% (−1.4 to 21.4),5.4% (−2.4 to 16.6),7.2% (1.4 to 15.3) *
144,All causes,Non-communicable diseases,Neoplasms,Other neoplasms,Benign and in-situ intestinal neoplasms,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,0 (0 to 0),0 (0 to 0),0 (0 to 0),NA,NA,NA
145,All causes,Non-communicable diseases,Neoplasms,Other neoplasms,Benign and in-situ cervical and uterine neoplasms,NA,NA,NA,0,0,0,0,0,0,0,NA,NA,NA,NA,0 (0 to 0),0 (0 to 0),NA,NA,NA
146,All causes,Non-communicable diseases,Neoplasms,Other neoplasms,Other benign and in-situ neoplasms,111,77.4,148,126,89.7,150,237,186,278,9.48e-5,29.1% (18.4 to 45.4) *,21.5% (5.6 to 39.3) *,25.0% (12.7 to 38.6) *,2.9 (2.0 to 3.9),3.4 (2.4 to 4.1),3.2 (2.5 to 3.7),18.7% (8.9 to 33.9) *,10.6% (−4.1 to 26.8),14.3% (3.0 to 27.0) *
147,All causes,Non-communicable diseases,Cardiovascular diseases,NA,NA,210000,204000,216000,156000,150000,162000,366000,355000,377000,0.1464,17.1% (15.3 to 19.0) *,15.4% (13.5 to 17.5) *,16.4% (15.0 to 17.8) *,5588.6 (5428.4 to 5743.1),3680.1 (3541.4 to 3821.0),4597.9 (4463.7 to 4734.2),−9.3% (−10.7 to −7.8) *,−10.8% (−12.4 to −9.3) *,−9.9% (−11.0 to −8.8) *
148,All causes,Non-communicable diseases,Cardiovascular diseases,Rheumatic heart disease,NA,4110,3710,4630,5280,4710,5950,9390,8580,10300,0.003756,−9.2% (−14.6 to −4.0) *,−3.1% (−8.6 to 2.4),−5.9% (−10.6 to −2.2) *,106.9 (96.7 to 120.0),130.3 (116.1 to 147.3),118.7 (108.5 to 130.7),−23.8% (−28.3 to −19.5) *,−19.6% (−24.3 to −14.9) *,−21.5% (−25.4 to −18.2) *
149,All causes,Non-communicable diseases,Cardiovascular diseases,Ischaemic heart disease,NA,105000,103000,108000,65300,63300,67200,170000,167000,174000,0.068,17.8% (15.7 to 20.0) *,17.0% (14.6 to 19.4) *,17.5% (15.7 to 19.2) *,2776 (2715.3 to 2843.4),1534.3 (1487.3 to 1580.5),2132.1 (2093.7 to 2179.8),−9.2% (−10.8 to −7.6) *,−10.4% (−12.3 to −8.6) *,−9.7% (−11.0 to −8.4) *
150,All causes,Non-communicable diseases,Cardiovascular diseases,Stroke,NA,72200,69400,75000,59900,56700,63000,132000,126000,137000,0.0528,17.4% (14.6 to 20.1) *,13.6% (10.9 to 16.4) *,15.7% (13.5 to 17.7) *,1924.7 (1848.8 to 1998.4),1412.1 (1336.8 to 1485.8),1657.2 (1587.4 to 1723.8),−9.9% (−11.9 to −7.9) *,−12.5% (−14.6 to −10.4) *,−11.0% (−12.6 to −9.4) *
151,All causes,Non-communicable diseases,Cardiovascular diseases,Stroke,Ischaemic stroke,28500,26400,30600,26700,24400,29000,55100,50900,59400,0.02204,28.6% (25.0 to 32.2) *,20.8% (17.3 to 24.2) *,24.7% (21.8 to 27.5) *,790.0 (732.7 to 846.5),625.2 (570.9 to 679.3),702.8 (649.5 to 756.5),−3.7% (−6.3 to −1.0) *,−8.1% (−10.8 to −5.6) *,−5.8% (−8.0 to −3.7) *
152,All causes,Non-communicable diseases,Cardiovascular diseases,Stroke,Intracerebral haemorrhage,37400,35900,38900,27200,25900,28500,64500,62300,66600,0.0258,10.7% (7.5 to 14.2) *,7.9% (4.4 to 11.6) *,9.5% (6.7 to 12.0) *,971.6 (933.9 to 1011.4),641.7 (611.1 to 673.3),800.3 (773.3 to 826.1),−14.5% (−16.9 to −11.8) *,−16.4% (−19.1 to −13.6) *,−15.2% (−17.4 to −13.3) *
153,All causes,Non-communicable diseases,Cardiovascular diseases,Stroke,Subarachnoid haemorrhage,6350,5680,7240,6060,5610,6780,12400,11600,13700,0.00496,13.4% (7.6 to 24.3) *,10.9% (7.1 to 14.7) *,12.2% (8.5 to 17.3) *,163.1 (145.8 to 185.9),145.2 (134.5 to 162.8),154.1 (143.7 to 170.1),−8.8% (−13.7 to −0.5) *,−12.0% (−15.0 to −9.0) *,−10.4% (−13.3 to −6.4) *
154,All causes,Non-communicable diseases,Cardiovascular diseases,Hypertensive heart disease,NA,7880,5500,8620,8660,6730,9560,16500,12700,17900,0.0066,39.5% (19.4 to 51.3) *,32.2% (19.7 to 45.7) *,35.6% (20.5 to 46.6) *,214.6 (149.8 to 234.1),203.2 (158.1 to 224.5),209.4 (160.5 to 226.3),7.0% (−8.7 to 15.5),0.9% (−8.4 to 10.8),3.7% (−7.9 to 11.8)
155,All causes,Non-communicable diseases,Cardiovascular diseases,Non-rheumatic valvular heart disease,NA,1270,1130,1400,1260,1100,1420,2530,2290,2770,0.001012,23.6% (19.2 to 27.7) *,23.7% (19.3 to 28) *,23.6% (20.6 to 26.5) *,36.0 (31.6 to 39.7),29.6 (26.0 to 33.5),32.7 (29.5 to 36.0),−5.0% (−8.2 to −1.8) *,−5.6% (−8.4 to −2.2) *,−5.5% (−7.5 to −3.2) *
156,All causes,Non-communicable diseases,Cardiovascular diseases,Non-rheumatic valvular heart disease,Non-rheumatic calcific aortic valve disease,793,682,873,720,595,818,1510,1340,1650,6.04e-4,32.1% (26.1 to 36.8) *,30.5% (23.7 to 36.1) *,31.3% (26.4 to 35.6) *,22.9 (19.5 to 25.1),16.8 (14.0 to 19.1),19.8 (17.5 to 21.5),−0.3% (−4.3 to 3.2),−2.5% (−6.7 to 1.2),−1.5% (−4.7 to 1.4)
157,All causes,Non-communicable diseases,Cardiovascular diseases,Non-rheumatic valvular heart disease,Non-rheumatic degenerative mitral valve disease,408,340,480,466,381,577,874,748,1010,3.496e-4,12.5% (7.0 to 19.9) *,16.4% (10.8 to 22.3) *,14.6% (9.8 to 19.8) *,11.2 (9.4 to 13.2),11.1 (9.1 to 13.7),11.2 (9.5 to 12.9),−12.1% (−16.1 to −6.3) *,−9.1% (−13.0 to −4.7) *,−10.7% (−14.3 to −6.7) *
158,All causes,Non-communicable diseases,Cardiovascular diseases,Non-rheumatic valvular heart disease,Other non-rheumatic valve diseases,71.5,46.3,103,70.6,48.9,102,142,109,190,5.68e-5,7.2% (−4.1 to 29.7),9.7% (−1.3 to 32.3),8.5% (−1.8 to 27.8),1.9 (1.2 to 2.8),1.7 (1.2 to 2.5),1.8 (1.4 to 2.4),−13.3% (−23.3 to 7.0),−11.0% (−20.1 to 7.4),−12.2% (−21.0 to 4.7)
159,All causes,Non-communicable diseases,Cardiovascular diseases,Cardiomyopathy and myocarditis,NA,6530,5880,7020,3720,3490,4010,10200,9500,10900,0.00408,−3.6% (−9.6 to 12.4),−4.2% (−7.1 to −0.2) *,−3.8% (−8.1 to 6.4),168.8 (152.5 to 181.2),92.8 (86.9 to 100.2),130.3 (121.0 to 138.8),−19.9% (−24.7 to −6.8) *,−21.5% (−23.8 to −18.4) *,−20.6% (−24.1 to −12.5) *
160,All causes,Non-communicable diseases,Cardiovascular diseases,Cardiomyopathy and myocarditis,Myocarditis,745,625,894,646,561,723,1390,1220,1560,5.56e-4,6.2% (−2.2 to 17.6),−4.3% (−10.6 to 5.0),1.0% (−5.3 to 8.3),19.9 (16.7 to 23.7),16.7 (14.5 to 18.7),18.3 (16.1 to 20.4),−9.3% (−16.7 to 0.6),−19.1% (−24.5 to −11.2) *,−14.2% (−19.6 to −7.2) *
161,All causes,Non-communicable diseases,Cardiovascular diseases,Cardiomyopathy and myocarditis,Alcoholic cardiomyopathy,2330,1990,2530,660,610,750,2990,2720,3210,0.001196,−26.9% (−32 to −0.2) *,−37.1% (−40 to −31.7) *,−29.4% (−33.5 to −11.1) *,57.6 (49.2 to 62.7),15.9 (14.6 to 18.0),36.4 (33.2 to 39.1),−39.7% (−43.9 to −18.2) *,−49.0% (−51.3 to −44.6) *,−42.2% (−45.5 to −27.5) *
162,All causes,Non-communicable diseases,Cardiovascular diseases,Cardiomyopathy and myocarditis,Other cardiomyopathy,3450,3050,3800,2420,2160,2640,5870,5290,6390,0.002348,19.7% (12.7 to 25.7) *,11.7% (7.6 to 17.6) *,16.3% (11.6 to 20.3) *,91.4 (81.2 to 100.1),60.3 (53.8 to 65.9),75.6 (68.3 to 82.1),−2.2% (−7.6 to 2.7),−9.5% (−12.7 to −5.2) *,−5.3% (−8.9 to −2.1) *
163,All causes,Non-communicable diseases,Cardiovascular diseases,Atrial fibrillation and flutter,NA,2850,2360,3460,3120,2690,3640,5980,5040,7090,0.002392,36.0% (33.1 to 38.5) *,35.8% (34.1 to 37.9) *,35.9% (34.3 to 37.8) *,84.0 (70.0 to 101.4),72.7 (62.6 to 84.9),78.0 (66.1 to 92.0),−0.1% (−2.2 to 1.6),1.1% (−0.1 to 2.6),0.5% (−0.5 to 1.7)
164,All causes,Non-communicable diseases,Cardiovascular diseases,Aortic aneurysm,NA,2090,1950,2250,949,907,1050,3040,2880,3190,0.001216,17.9% (12.9 to 23.6) *,21.6% (16.2 to 25.9) *,19.0% (14.5 to 23.6) *,56.0 (52.3 to 60.2),22.3 (21.4 to 24.7),38.2 (36.2 to 40.0),−9.9% (−13.6 to −5.7) *,−6.6% (−10.6 to −3.2) *,−8.5% (−11.9 to −5.1) *
165,All causes,Non-communicable diseases,Cardiovascular diseases,Peripheral vascular disease,NA,759,513,1190,674,395,1150,1430,970,2130,5.72e-4,40.6% (22.7 to 52.9) *,39.8% (23.3 to 55.6) *,40.2% (25.9 to 53.5) *,21.4 (14.4 to 33.9),15.7 (9.2 to 26.7),18.4 (12.5 to 27.6),4.1% (−9.0 to 13.4),4.1% (−8.1 to 15.4),4.1% (−6.5 to 13.9)
166,All causes,Non-communicable diseases,Cardiovascular diseases,Endocarditis,NA,1160,1090,1230,1070,920,1220,2230,2080,2420,8.92e-4,20.6% (11.0 to 26.2) *,13.6% (5.9 to 20.5) *,17.1% (9.3 to 22.3) *,30.8 (28.9 to 32.7),27.3 (23.5 to 31.1),29.0 (27.1 to 31.7),0.8% (−6.7 to 5.2),−5.2% (−11.4 to 0.6),−2.3% (−8.6 to 2.0)
167,All causes,Non-communicable diseases,Cardiovascular diseases,Other cardiovascular and circulatory diseases,NA,6420,5620,7410,5730,4950,6750,12200,10600,14000,0.00488,15.3% (12.3 to 18.4) *,17.1% (14.2 to 21.3) *,16.2% (13.6 to 18.6) *,169.4 (148.6 to 195.5),139.8 (120.4 to 163.9),153.8 (134.7 to 176.5),−7.5% (−9.9 to −5.2) *,−5.8% (−8.2 to −2.6) *,−6.7% (−8.7 to −5.0) *
168,All causes,Non-communicable diseases,Chronic respiratory diseases,NA,NA,58600,54900,62300,53700,49000,57900,112000,105000,120000,0.0448,10.7% (8.5 to 13.3) *,18.9% (14.8 to 23.6) *,14.5% (12.3 to 17.2) *,1586.3 (1489.1 to 1681.7),1293.2 (1178.8 to 1399.0),1422.9 (1326.6 to 1517.2),−14.2% (−16.1 to −12.1) *,−6.0% (−9.2 to −2.4) *,−10.2% (−12.0 to −8.1) *
169,All causes,Non-communicable diseases,Chronic respiratory diseases,Chronic obstructive pulmonary disease,NA,43300,40100,46100,38300,34900,41400,81600,76000,86800,0.03264,13.5% (10.3 to 16.9) *,21.2% (14.9 to 26.5) *,17.0% (13.7 to 20.0) *,1181.3 (1097.1 to 1255.3),906.4 (824.1 to 979.9),1028.8 (960.4 to 1092.5),−14.1% (−16.4 to −11.5) *,−6.3% (−11.1 to −2.3) *,−10.3% (−12.9 to −8.0) *
170,All causes,Non-communicable diseases,Chronic respiratory diseases,Pneumoconiosis,NA,453,421,489,54.1,45.7,63.1,507,472,548,2.028e-4,10.4% (4.3 to 17.1) *,11.8% (0.1 to 22.4) *,10.6% (5.2 to 16.6) *,12.1 (11.2 to 13.0),1.3 (1.1 to 1.5),6.3 (5.9 to 6.8),−15.6% (−20.1 to −10.7) *,−12.3% (−21.5 to −4.1) *,−14.4% (−18.6 to −9.8) *
171,All causes,Non-communicable diseases,Chronic respiratory diseases,Pneumoconiosis,Silicosis,247,220,272,13.3,8.66,17,261,233,286,1.044e-4,13.0% (0.3 to 24.2) *,17.8% (6.0 to 31.2) *,13.2% (1.2 to 24.1) *,6.5 (5.8 to 7.2),0.3 (0.2 to 0.4),3.2 (2.9 to 3.5),−13.6% (−23.1 to −5.1) *,−7.6% (−17.0 to 3.0),−12.3% (−21.6 to −3.9) *
172,All causes,Non-communicable diseases,Chronic respiratory diseases,Pneumoconiosis,Asbestosis,57.3,41.7,67.9,11.7,8.38,15,69.1,52.2,81.4,2.7639999999999996e-5,20.2% (12.3 to 31.3) *,14.7% (0.8 to 32.0) *,19.2% (11.8 to 30.4) *,1.6 (1.2 to 1.9),0.3 (0.2 to 0.4),0.9 (0.7 to 1.0),−9.1% (−14.9 to −0.7) *,−10.5% (−21.3 to 3.4),−8.5% (−14.1 to 0.3)
173,All causes,Non-communicable diseases,Chronic respiratory diseases,Pneumoconiosis,Coal worker pneumoconiosis,74.6,63,92.9,6.24,4,8.12,80.8,69,100,3.2319999999999995e-5,−0.6% (−10.0 to 12.9),9.0% (−2.8 to 27.2),0.1% (−8.8 to 12.9),2.0 (1.7 to 2.5),0.1 (0.1 to 0.2),1.0 (0.9 to 1.3),−24.3% (−31.2 to −14.5) *,−14.8% (−24.0 to −0.6) *,−23% (−29.8 to −13.3) *
174,All causes,Non-communicable diseases,Chronic respiratory diseases,Pneumoconiosis,Other pneumoconiosis,74.1,61.6,94.6,22.8,17.6,28.8,96.9,81.8,117,3.876e-5,7.4% (−1.2 to 22.6),8.1% (−3.9 to 19.7),7.6% (0.6 to 20.5) *,2.0 (1.6 to 2.5),0.5 (0.4 to 0.7),1.2 (1.0 to 1.5),−16.6% (−23.4 to −4.8) *,−15.0% (−24.6 to −5.9) *,−15.9% (−21.4 to −5.5) *
175,All causes,Non-communicable diseases,Chronic respiratory diseases,Asthma,NA,11000,8470,14100,11700,9050,14800,22800,18100,28300,0.00912,−2.7% (−8.9 to 4.8),9.7% (4.3 to 17.0) *,3.3% (−1.1 to 9.0),290.1 (223.0 to 371.5),297.4 (229.0 to 376.2),293.3 (232.4 to 365.2),−19.3% (−25.5 to −10.8) *,−8.2% (−13.6 to −0.9) *,−13.7% (−18.2 to −7.9) *
176,All causes,Non-communicable diseases,Chronic respiratory diseases,Interstitial lung disease and pulmonary sarcoidosis,NA,1840,1490,2390,1530,1160,2000,3360,2770,4080,0.001344,40.6% (25.8 to 49.7) *,39.5% (25.2 to 53.3) *,40.1% (31.5 to 47.8) *,49.8 (40.1 to 64.4),36.2 (27.5 to 47.5),42.3 (34.8 to 51.4),7.9% (−3.0 to 14.7),8.3% (−2.6 to 19.1),8.3% (1.8 to 14.3) *
177,All causes,Non-communicable diseases,Chronic respiratory diseases,Other chronic respiratory diseases,NA,2070,1820,2360,2010,1740,2280,4080,3600,4560,0.001632,14.8% (9.5 to 22.0) *,21.3% (14.8 to 29.3) *,17.9% (13.2 to 24.5) *,53.0 (46.6 to 60.4),51.9 (44.7 to 58.9),52.1 (46.1 to 58.2),−1.7% (−6.3 to 4.3),6.0% (0.1 to 13.5) *,2.0% (−2.2 to 7.8)
178,All causes,Non-communicable diseases,Digestive diseases,NA,NA,52800,48500,58200,32500,29100,36800,85300,78000,94500,0.03412,9.9% (6.7 to 16.1) *,10.9% (8.1 to 14.4) *,10.3% (7.5 to 14.3) *,1346.7 (1237.4 to 1486.3),803.1 (717.1 to 911.3),1070.8 (979.3 to 1187.9),−9.6% (−12.2 to −4.5) *,−8.9% (−11.5 to −6.0) *,−9.4% (−11.7 to −6.0) *
179,All causes,Non-communicable diseases,Digestive diseases,Cirrhosis and other chornic liver diseases,NA,28800,27300,31400,12600,11900,14700,41400,39600,45100,0.01656,9.9% (4.3 to 16.4) *,9.4% (2.9 to 15.5) *,9.8% (4.5 to 15.2) *,719.3 (683.0 to 784.9),307.6 (288.5 to 359.6),510.7 (487.6 to 557.1),−10.2% (−14.8 to −4.9) *,−11.2% (−16.5 to −6.3) *,−10.6% (−14.9 to −6.3) *
180,All causes,Non-communicable diseases,Digestive diseases,Cirrhosis and other chornic liver diseases,Cirrhosis and other chronic liver diseases due to hepatitis B,9190,8310,10500,3020,2700,3600,12200,11100,13900,0.00488,4.5% (−2.3 to 11.9),3.9% (−4.3 to 13.3),4.3% (−2.2 to 11.4),229.5 (208.0 to 261.6),72.9 (65.0 to 86.8),150.1 (136.2 to 170.3),−14.3% (−20 to −8.2) *,−15.8% (−22.4 to −8.4) *,−14.7% (−20.0 to −8.9) *
181,All causes,Non-communicable diseases,Digestive diseases,Cirrhosis and other chornic liver diseases,Cirrhosis and other chronic liver diseases due to hepatitis C,7160,6450,8000,3250,2950,3700,10400,9470,11600,0.00416,13.0% (7.5 to 19.1) *,13.1% (6.0 to 20.0) *,13.0% (7.7 to 18.1) *,178.1 (160.8 to 198.8),77.8 (70.7 to 88.4),127.2 (115.9 to 141.8),−8.5% (−12.9 to −3.7) *,−9.6% (−15.2 to −4.4) *,−8.9% (−13.1 to −4.9) *
182,All causes,Non-communicable diseases,Digestive diseases,Cirrhosis and other chornic liver diseases,Cirrhosis and other chronic liver diseases due to alcohol use,7660,6980,8450,2530,2290,2980,10200,9310,11300,0.00408,13.0% (7.8 to 19.0) *,13.3% (7.2 to 22.4) *,13.1% (8.1 to 18.9) *,189.6 (173.1 to 209.1),60.2 (54.5 to 70.8),123.9 (113.2 to 138.1),−8.8% (−13.2 to −4) *,−10.3% (−15.2 to −3.3) *,−9.3% (−13.4 to −4.8) *
183,All causes,Non-communicable diseases,Digestive diseases,Cirrhosis and other chornic liver diseases,Cirrhosis due to NASH,2110,1920,2310,1330,1220,1470,3430,3150,3740,0.001372,24.3% (18.4 to 30.1) *,21.9% (15.4 to 27.6) *,23.4% (17.8 to 28.3) *,52.2 (47.8 to 57.3),31.6 (29.0 to 35.0),41.8 (38.5 to 45.5),−0.6% (−5.2 to 4.2),−4.1% (−9.2 to 0.3),−2.0% (−6.4 to 1.9)
184,All causes,Non-communicable diseases,Digestive diseases,Cirrhosis and other chornic liver diseases,Cirrhosis and other chronic liver diseases due to other causes,2660,2370,3000,2500,2220,2960,5160,4650,5760,0.002064,3.6% (−3.7 to 13.8),2.5% (−4.5 to 11.5),3.1% (−3.0 to 11.2),70.0 (62.7 to 78.6),65.2 (57.7 to 77.8),67.7 (61.1 to 75.4),−10.5% (−16.8 to −1.6) *,−11.8% (−18.2 to −3.9) *,−11.1% (−16.5 to −3.9) *
185,All causes,Non-communicable diseases,Digestive diseases,Upper digestive system diseases,NA,10200,7880,13400,9640,7080,13200,19800,15100,26600,0.00792,7.4% (2.3 to 12.3) *,12.7% (9.4 to 15.7) *,9.9% (6.0 to 13.4) *,261.0 (202.6 to 342.2),237.4 (173.6 to 324.9),248.7 (189.1 to 333.3),−11.5% (−16.1 to −7.2) *,−6.6% (−9.7 to −3.8) *,−9.1% (−12.7 to −5.9) *
186,All causes,Non-communicable diseases,Digestive diseases,Upper digestive system diseases,Peptic ulcer disease,3740,3440,4200,2610,2270,2910,6350,5900,6870,0.00254,−7.2% (−12.8 to −1.0) *,0.7% (−4.3 to 6.9),−4.1% (−8.5 to 0.9),96.9 (89.1 to 108.9),63.2 (55.0 to 70.7),79.6 (73.9 to 86.2),−25.4% (−29.9 to −20.5) *,−19.1% (−23.2 to −14.1) *,−22.9% (−26.5 to −18.9) *
187,All causes,Non-communicable diseases,Digestive diseases,Upper digestive system diseases,Gastritis and duodenitis,3470,2500,4700,4000,2750,5550,7470,5240,10200,0.002988,16.4% (11.8 to 21.0) *,15.7% (12.8 to 18.7) *,16.1% (13.0 to 19.1) *,89.1 (64.1 to 120.1),99.7 (68.4 to 138.5),94.3 (66.4 to 129.1),−2.0% (−6.0 to 1.9),−2.7% (−5.3 to −0.3) *,−2.3% (−5.1 to 0.4)
188,All causes,Non-communicable diseases,Digestive diseases,Upper digestive system diseases,Gastro-oesophageal reflux disease,2980,1590,5020,3040,1630,5150,6010,3220,10200,0.002404,20.3% (18.6 to 22.2) *,21.0% (19.3 to 22.8) *,20.7% (19.1 to 22.3) *,75.1 (40.1 to 126.9),74.5 (40.1 to 126.9),74.8 (40.1 to 126.9),1.2% (0.1 to 2.3) *,1.4% (0.4 to 2.4) *,1.3% (0.6 to 2.0) *
189,All causes,Non-communicable diseases,Digestive diseases,Appendicitis,NA,910,813,1030,947,799,1050,1860,1680,2020,7.44e-4,−7.3% (−16.6 to 3.8),−6.2% (−14.3 to 2.8),−6.7% (−14.1 to 1.6),23.9 (21.4 to 27),25.0 (21.1 to 27.7),24.4 (22.0 to 26.5),−19% (−27.1 to −9.5) *,−17.3% (−24.8 to −9.0) *,−18.1% (−24.7 to −10.6) *
190,All causes,Non-communicable diseases,Digestive diseases,Paralytic ileus and intestinal obstruction,NA,4080,3230,4700,3210,2350,3650,7290,5910,8030,0.002916,5.9% (−4.9 to 17.8),7.4% (−3.2 to 18.7),6.6% (−2.9 to 15.5),110.7 (88.4 to 127.2),84.9 (62.3 to 96.2),97.6 (79.4 to 107.4),−8.9% (−18.0 to 1.0),−8.2% (−17.1 to 1.5),−8.6% (−16.7 to −0.8) *
191,All causes,Non-communicable diseases,Digestive diseases,"Inguinal, femoral, and abdominal hernia",NA,2490,1860,3230,989,753,1250,3480,2610,4480,0.001392,13.3% (10.1 to 16.7) *,15.2% (11.9 to 19.7) *,13.9% (11.0 to 16.8) *,65.5 (49.1 to 84.6),25.0 (18.9 to 31.8),44.8 (33.6 to 57.5),−5.3% (−8.0 to −2.6) *,−4.4% (−7.2 to −1.1) *,−5.0% (−7.3 to −2.7) *
192,All causes,Non-communicable diseases,Digestive diseases,Inflammatory bowel disease,NA,885,741,1050,964,751,1180,1850,1510,2230,7.4e-4,16.8% (8.4 to 23.2) *,15.8% (8.3 to 21.0) *,16.3% (8.8 to 21.4) *,23.0 (19.3 to 27.2),23.5 (18.3 to 28.6),23.2 (19.1 to 27.8),−5.0% (−11.5 to 0.1),−6.2% (−12.2 to −2.1) *,−5.6% (−11.5 to −1.9) *
193,All causes,Non-communicable diseases,Digestive diseases,Vascular intestinal disorders,NA,806,742,866,791,688,869,1600,1460,1700,6.4e-4,16.9% (9.5 to 28.2) *,18.6% (12.1 to 24.5) *,17.7% (11.0 to 24.8) *,21.9 (20.2 to 23.6),18.6 (16.1 to 20.5),20.4 (18.7 to 21.6),−10.1% (−15.6 to −2.3) *,−9.4% (−14.4 to −4.9) *,−9.9% (−15.0 to −4.9) *
194,All causes,Non-communicable diseases,Digestive diseases,Gallbladder and biliary diseases,NA,940,882,1040,1070,933,1140,2010,1890,2130,8.04e-4,22.5% (15.6 to 31.7) *,15.3% (9.9 to 23.9) *,18.6% (13.6 to 25.3) *,25.7 (24.2 to 28.4),25.8 (22.4 to 27.7),25.7 (24.1 to 27.2),−3.8% (−8.9 to 3.0),−9.2% (−13.6 to −2.3) *,−6.8% (−10.8 to −1.7) *
195,All causes,Non-communicable diseases,Digestive diseases,Pancreatitis,NA,2210,1950,2470,1050,831,1210,3250,2890,3610,0.0013,14.7% (7.4 to 21.7) *,15.9% (8.8 to 22.6) *,15.1% (10.6 to 20.5) *,55.6 (49.2 to 62.2),25.3 (20.0 to 29.3),40.3 (35.9 to 44.7),−5.2% (−11 to 0.5),−6.9% (−12.5 to −1.5) *,−5.9% (−9.5 to −1.6) *
196,All causes,Non-communicable diseases,Digestive diseases,Other digestive diseases,NA,1510,1300,1750,1210,1050,1380,2720,2380,3110,0.001088,22.3% (11.7 to 34.6) *,18.8% (12.2 to 26.9) *,20.7% (12.9 to 28.4) *,40.2 (34.7 to 46.3),30.0 (26.0 to 34.4),35.0 (30.7 to 40.0),−0.4% (−8.3 to 9.2),−3.7% (−9.2 to 3.1),−1.9% (−8.2 to 4.1)
197,All causes,Non-communicable diseases,Neurological disorders,NA,NA,46300,37200,57200,64900,51100,81400,111000,88500,139000,0.0444,20.5% (18.4 to 23.3) *,20.6% (18.9 to 22.4) *,20.5% (18.8 to 22.6) *,1275.1 (1036.4 to 1554.8),1606.9 (1256.7 to 2030.1),1444.4 (1154 to 1792.7),−0.1% (−1.9 to 2.0),−0.2% (−1.5 to 1.2),−0.2% (−1.6 to 1.4)
198,All causes,Non-communicable diseases,Neurological disorders,Alzheimer's disease and other dementias,NA,11700,10900,12500,18900,17600,20200,30500,28500,32600,0.0122,41.8% (38.0 to 44.4) *,36.1% (32.8 to 38.2) *,38.3% (36.0 to 40.1) *,376.8 (352.1 to 404.4),436.2 (407.7 to 466.2),412.6 (385.7 to 440.3),0.5% (−2.0 to 2.1),−0.9% (−3.2 to 0.6),−0.6% (−2.2 to 0.6)
199,All causes,Non-communicable diseases,Neurological disorders,Parkinson's disease,NA,3190,2940,3500,2390,2200,2630,5580,5150,6080,0.002232,36.1% (31.2 to 39.3) *,31.0% (26.5 to 34.0) *,33.9% (29.7 to 36.4) *,94.0 (86.7 to 103.1),55.9 (51.3 to 61.3),72.5 (66.9 to 79.0),0.2% (−3.4 to 2.5),−0.7% (−4.0 to 1.6),0.4% (−2.7 to 2.3)
200,All causes,Non-communicable diseases,Neurological disorders,Epilepsy,NA,7910,6200,10100,6880,5220,8960,14800,11400,19000,0.00592,4.3% (−3.3 to 15.0),7.7% (−1 to 18.2),5.8% (−2.0 to 15.9),208.1 (162.8 to 266.7),183.5 (139.3 to 239.7),195.8 (151.4 to 251.8),−6.4% (−13.2 to 3.2),−3.8% (−11.4 to 5.4),−5.2% (−12.2 to 3.7)
201,All causes,Non-communicable diseases,Neurological disorders,Multiple sclerosis,NA,408,354,459,677,579,781,1080,943,1240,4.32e-4,17.9% (9.3 to 21.6) *,17.4% (11.1 to 22.3) *,17.6% (10.2 to 21.9) *,10.1 (8.8 to 11.4),16.3 (14.0 to 18.9),13.3 (11.5 to 15.2),−3.8% (−10.3 to −0.8) *,−4.5% (−9.1 to −0.4) *,−4.2% (−9.8 to −0.6) *
202,All causes,Non-communicable diseases,Neurological disorders,Motor neuron disease,NA,508,481,556,371,345,407,879,841,966,3.516e-4,27.9% (21 to 31.9) *,26.1% (20.0 to 31.1) *,27.2% (22.9 to 30.9) *,13.1 (12.4 to 14.3),9.0 (8.3 to 9.8),11.0 (10.5 to 12.0),1.4% (−3.8 to 4.5),−1.0% (−5.8 to 2.9),0.3% (−3.1 to 3.3)
203,All causes,Non-communicable diseases,Neurological disorders,Headache disorders,NA,20500,13400,29300,33900,22200,48100,54300,35600,76800,0.02172,15.5% (14.5 to 16.5) *,15.3% (14.4 to 16.2) *,15.4% (14.6 to 16.2) *,516.5 (338 to 738.7),857.0 (561.5 to 1217.0),686.5 (448.7 to 970.5),1.5% (0.8 to 2.3) *,0.7% (0.1 to 1.3) *,1.0% (0.5 to 1.5) *
204,All causes,Non-communicable diseases,Neurological disorders,Headache disorders,Migraine,17300,10900,25500,29900,19000,42900,47200,30000,68700,0.01888,15.5% (14.4 to 16.7) *,15.2% (14.2 to 16.2) *,15.3% (14.5 to 16.2) *,437.7 (273.7 to 645.5),756.5 (480.9 to 1088.1),596.8 (378.2 to 866),1.7% (0.9 to 2.6) *,0.8% (0.1 to 1.5) *,1.1% (0.6 to 1.7) *
205,All causes,Non-communicable diseases,Neurological disorders,Headache disorders,Tension-type headache,3110,1740,5000,3990,2270,6230,7100,4040,11200,0.00284,15.3% (14.1 to 16.7) *,15.8% (14.6 to 17.2) *,15.6% (14.5 to 16.9) *,78.8 (44.4 to 126.9),100.5 (57.2 to 157.6),89.7 (51.0 to 142.2),0.5% (0 to 1.0),0.1% (−0.4 to 0.6),0.3% (−0.1 to 0.6)
206,All causes,Non-communicable diseases,Neurological disorders,Other neurological disorders,NA,2130,1780,2570,1830,1480,2300,3970,3270,4850,0.001588,19.1% (10.1 to 28.5) *,22.4% (11.4 to 32.8) *,20.6% (12.5 to 29.7) *,56.4 (47.3 to 68),49.1 (39.2 to 61.9),52.7 (43.3 to 64.7),6.3% (−1.9 to 14.6),8.2% (−1.6 to 17.6),7.2% (−0.3 to 15.3)
207,All causes,Non-communicable diseases,Mental disorders,NA,NA,56200,41800,72700,66500,49700,85700,123000,91600,158000,0.0492,13.4% (12.7 to 14.0) *,13.6% (12.9 to 14.4) *,13.5% (12.9 to 14.1) *,1435.0 (1065.8 to 1856.2),1681.8 (1255.2 to 2169.0),1560.4 (1165.1 to 2010.5),−0.6% (−1.1 to −0.2) *,−1.5% (−2.1 to −1.0) *,−1.1% (−1.5 to −0.7) *
208,All causes,Non-communicable diseases,Mental disorders,Schizophrenia,NA,6510,4860,8020,6140,4610,7540,12700,9480,15600,0.00508,16.7% (15.4 to 18.2) *,17.7% (16.3 to 19.2) *,17.2% (16.1 to 18.3) *,161.6 (120.5 to 198.9),151.3 (113.2 to 185.8),156.4 (117.1 to 192.3),−0.4% (−1.4 to 0.6),−0.2% (−1.3 to 0.9),−0.3% (−1.1 to 0.4)
209,All causes,Non-communicable diseases,Mental disorders,Depressive disorders,NA,16800,11900,22900,26300,18700,35900,43100,30500,58900,0.01724,14.8% (13.5 to 16.2) *,14.1% (12.8 to 15.5) *,14.3% (13.1 to 15.6) *,425.1 (300.8 to 579.9),653.5 (462.2 to 892.4),540.5 (382.4 to 737.8),−1.9% (−2.8 to −1.0) *,−3.1% (−4.1 to −2.1) *,−2.6% (−3.5 to −1.8) *
210,All causes,Non-communicable diseases,Mental disorders,Depressive disorders,Major depressive disorder,12700,8910,17300,20100,14200,27000,32800,23100,44300,0.01312,13.2% (11.8 to 14.6) *,12.2% (10.7 to 13.7) *,12.6% (11.3 to 14.0) *,323.6 (225.9 to 439.5),500.9 (352.5 to 676.7),413.0 (289.8 to 558.9),−2.7% (−3.8 to −1.8) *,−4.2% (−5.3 to −3.1) *,−3.6% (−4.6 to −2.7) *
211,All causes,Non-communicable diseases,Mental disorders,Depressive disorders,Dysthymia,4030,2690,5880,6220,4180,9090,10300,6880,15000,0.00412,20.2% (17.4 to 23.2) *,20.6% (17.7 to 23.5) *,20.4% (18.2 to 22.6) *,101.5 (67.9 to 148.0),152.7 (102.4 to 222.6),127.4 (85.4 to 185.6),1.0% (−1.0 to 3.0),0.6% (−1.4 to 2.8),0.8% (−0.8 to 2.3)
212,All causes,Non-communicable diseases,Mental disorders,Bipolar disorder,NA,4490,2820,6630,4810,3030,7100,9290,5870,13700,0.003716,15.3% (14.0 to 16.8) *,15.2% (13.8 to 16.7) *,15.2% (14.0 to 16.6) *,113.4 (71.3 to 167.4),121.6 (76.8 to 179.5),117.5 (74.1 to 173.5),1.5% (0.7 to 2.3) *,0.9% (0.1 to 1.8) *,1.2% (0.6 to 1.8) *
213,All causes,Non-communicable diseases,Mental disorders,Anxiety disorders,NA,10200,7200,13500,17000,12000,22500,27100,19200,36100,0.01084,13.6% (12.2 to 15.1) *,12.4% (11.0 to 13.8) *,12.8% (11.7 to 14.0) *,259.2 (183.1 to 343.3),431.9 (306.8 to 575.5),345.7 (245.6 to 459.7),0% (−1.1 to 1.1),−1.9% (−2.9 to −0.7) *,−1.2% (−2.0 to −0.4) *
214,All causes,Non-communicable diseases,Mental disorders,Eating disorders,NA,1050,662,1530,2320,1500,3370,3370,2170,4890,0.001348,20.7% (18.4 to 22.9) *,18.2% (16.4 to 19.8) *,18.9% (17.3 to 20.5) *,26.7 (16.8 to 39.1),60.5 (39.2 to 87.6),43.4 (27.9 to 62.9),10.7% (8.8 to 12.4) *,8.9% (7.6 to 10.3) *,9.4% (8.2 to 10.5) *
215,All causes,Non-communicable diseases,Mental disorders,Eating disorders,Anorexia nervosa,143,87.8,215,585,365,864,728,454,1080,2.912e-4,13.8% (9.4 to 18.2) *,13.4% (10.8 to 16.0) *,13.5% (11.1 to 15.7) *,3.7 (2.3 to 5.6),15.5 (9.6 to 22.8),9.5 (5.9 to 14.1),6.7% (3.0 to 10.6) *,6.2% (3.9 to 8.5) *,6.1% (4.2 to 8.1) *
216,All causes,Non-communicable diseases,Mental disorders,Eating disorders,Bulimia nervosa,904,559,1340,1740,1100,2620,2640,1660,3940,0.001056,21.9% (19.3 to 24.3) *,19.8% (17.8 to 21.9) *,20.5% (18.7 to 22.1) *,22.9 (14.2 to 33.9),45.0 (28.6 to 67.8),33.8 (21.3 to 50.5),11.4% (9.3 to 13.2) *,9.9% (8.4 to 11.4) *,10.3% (9.0 to 11.6) *
217,All causes,Non-communicable diseases,Mental disorders,Autism spectrum disorders,NA,3590,2460,4940,1140,771,1570,4730,3240,6520,0.001892,11.1% (10.4 to 11.9) *,12.4% (11.3 to 13.6) *,11.4% (10.8 to 12.1) *,94 (64.4 to 129.2),30.4 (20.5 to 41.9),62.4 (42.7 to 86.0),−0.6% (−1.2 to 0.1),0.5% (−0.5 to 1.6),−0.3% (−0.8 to 0.3)
218,All causes,Non-communicable diseases,Mental disorders,Attention-deficit/hyperactivity disorder,NA,627,383,996,262,158,416,889,543,1410,3.556e-4,6.6% (4.4 to 8.6) *,7.7% (5.3 to 10.0) *,6.9% (5.2 to 8.5) *,16.5 (10.0 to 26.2),7.1 (4.3 to 11.3),11.9 (7.3 to 18.9),−0.8% (−2.9 to 1.1),0% (−2.2 to 2.2),−0.6% (−2.1 to 0.8)
219,All causes,Non-communicable diseases,Mental disorders,Conduct disorder,NA,4190,2520,6630,2250,1330,3650,6450,3870,10300,0.00258,4.1% (1.9 to 6.1) *,6.3% (4.0 to 8.7) *,4.8% (3.1 to 6.5) *,113.8 (68.5 to 179.9),64.9 (38.2 to 105.5),90.0 (54.0 to 143.9),1.7% (−0.4 to 3.6),3.7% (1.4 to 5.8) *,2.4% (0.9 to 3.8) *
220,All causes,Non-communicable diseases,Mental disorders,Idiopathic developmental intellectual disability,NA,2200,1060,3740,1840,901,3080,4050,1940,6860,0.00162,0.6% (−2.0 to 2.0),−0.6% (−3.9 to 1.3),0% (−2.8 to 1.5),58.0 (28.0 to 98.6),50.4 (24.7 to 84.1),54.2 (26.1 to 91.9),−8.4% (−10.6 to −7.1) *,−9.1% (−12.0 to −7.5) *,−8.7% (−11.1 to −7.5) *
221,All causes,Non-communicable diseases,Mental disorders,Other mental disorders,NA,6640,4330,9180,4470,3010,6140,11100,7360,15300,0.00444,17.2% (16.5 to 18.0) *,18.2% (17.3 to 19.1) *,17.6% (17.0 to 18.3) *,166.8 (108.9 to 230.4),110.3 (74.2 to 151.5),138.4 (91.6 to 191),−0.1% (−0.7 to 0.5),0.1% (−0.6 to 0.8),0% (−0.4 to 0.5)
222,All causes,Non-communicable diseases,Substance use disorders,NA,NA,31900,25900,38400,12800,9930,15700,44700,35900,54100,0.01788,15.9% (13.5 to 18.1) *,20.8% (18.9 to 23.3) *,17.3% (15.2 to 19.3) *,797.5 (645.9 to 960.9),320.9 (248.9 to 395.7),559.2 (448.2 to 677.9),0.9% (−1.3 to 2.9),5.8% (4.2 to 8.0) *,2.3% (0.5 to 4.0) *
223,All causes,Non-communicable diseases,Substance use disorders,Alcohol use disorders,NA,13300,10900,16200,4170,3140,5420,17500,14100,21600,0.007,3.8% (0.8 to 6.1) *,9.4% (6.0 to 15.3) *,5.0% (2.4 to 7.4) *,329.7 (269.2 to 401.9),104.0 (78.1 to 134.8),216.4 (174.1 to 268.5),−11.4% (−14.1 to −9.3) *,−5.9% (−9.1 to −0.8) *,−10.2% (−12.7 to −8.1) *
224,All causes,Non-communicable diseases,Substance use disorders,Drug use disorders,NA,18600,14500,22900,8590,6660,10700,27200,21100,33600,0.01088,26.6% (23.5 to 29.9) *,27.3% (24.3 to 30.7) *,26.8% (24.2 to 29.6) *,467.7 (364.7 to 576.6),217.0 (168.1 to 270.9),342.8 (266.4 to 424.1),11.9% (9.3 to 14.7) *,12.4% (10.1 to 15.2) *,12.1% (9.9 to 14.5) *
225,All causes,Non-communicable diseases,Substance use disorders,Drug use disorders,Opioid use disorders,14800,11300,18700,6640,4960,8460,21500,16300,27100,0.0086,31.2% (27.6 to 34.9) *,29.8% (25.3 to 35.0) *,30.8% (27.5 to 34.4) *,372.9 (282.9 to 468.1),167.4 (124.8 to 214.1),270.5 (204.4 to 342.2),15.6% (12.3 to 18.9) *,14.4% (10.7 to 18.5) *,15.3% (12.4 to 18.3) *
226,All causes,Non-communicable diseases,Substance use disorders,Drug use disorders,Cocaine use disorders,698,531,900,293,215,391,992,747,1290,3.968e-4,17.2% (13.2 to 21.2) *,23.4% (14.9 to 35.6) *,19.0% (15.5 to 24.2) *,17.6 (13.3 to 22.7),7.4 (5.4 to 9.9),12.5 (9.4 to 16.3),3.3% (−0.2 to 6.7),8.7% (1.4 to 19.3) *,4.9% (1.9 to 9.3) *
227,All causes,Non-communicable diseases,Substance use disorders,Drug use disorders,Amphetamine use disorders,785,501,1150,399,253,593,1180,757,1740,4.72e-4,4.0% (−0.4 to 8.4),8.5% (2.7 to 16.7) *,5.5% (1.5 to 9.4) *,20.1 (12.7 to 29.5),10.4 (6.5 to 15.5),15.3 (9.7 to 22.6),−4.1% (−8.2 to −0.5) *,0.6% (−4.4 to 7.4),−2.5% (−6.2 to 0.4)
228,All causes,Non-communicable diseases,Substance use disorders,Drug use disorders,Cannabis use disorders,343,217,510,174,110,257,518,329,766,2.072e-4,5.4% (2.7 to 8.3) *,2.6% (−0.1 to 5.4),4.4% (2.2 to 6.6) *,8.8 (5.6 to 13.1),4.5 (2.9 to 6.7),6.7 (4.2 to 9.9),−2.8% (−5.4 to −0.2) *,−5.6% (−8.0 to −3.3) *,−3.7% (−5.7 to −1.7) *
229,All causes,Non-communicable diseases,Substance use disorders,Drug use disorders,Other drug use disorders,1920,1630,2260,1090,908,1300,3010,2550,3540,0.001204,12.9% (8.1 to 17.1) *,26.5% (14.5 to 41.6) *,17.5% (10.9 to 24.1) *,48.5 (41.0 to 57.2),27.2 (22.6 to 32.6),37.9 (32.1 to 44.7),−0.1% (−4.5 to 3.3),10.4% (0.1 to 22.9) *,3.5% (−2.2 to 8.9)
230,All causes,Non-communicable diseases,Diabetes and kidney diseases,NA,NA,54000,46900,62700,50000,43100,58000,104000,90100,121000,0.0416,27.1% (24.6 to 29.7) *,26.6% (24.1 to 29.2) *,26.9% (24.7 to 29.2) *,1399.8 (1218.1 to 1617.7),1197.7 (1033.3 to 1390.8),1294.2 (1122.0 to 1496.7),1.0% (−0.9 to 3.0),0.3% (−1.7 to 2.4),0.8% (−1.0 to 2.6)
231,All causes,Non-communicable diseases,Diabetes and kidney diseases,Diabetes mellitus,NA,35000,28500,42700,32900,26800,39900,67900,55400,82600,0.02716,30.4% (27.1 to 34.1) *,29.5% (26.4 to 32.9) *,30.0% (26.9 to 33.3) *,898.7 (733.5 to 1095.5),782.9 (638.0 to 951.0),839 (685.1 to 1020.0),2.9% (0.2 to 5.7) *,1.9% (−0.7 to 4.6),2.5% (0 to 5.1) *
232,All causes,Non-communicable diseases,Diabetes and kidney diseases,Diabetes mellitus,Type 1 diabetes mellitus,5270,4760,5820,5180,4640,5700,10400,9790,11100,0.00416,13.7% (9.5 to 18.3) *,9.3% (4.0 to 14) *,11.5% (7.9 to 14.5) *,133.6 (120.6 to 147.8),125.3 (112.6 to 138.1),129.4 (121.3 to 137.6),−7.7% (−11.4 to −4.0) *,−11.9% (−16.2 to −7.9) *,−9.8% (−12.8 to −7.2) *
233,All causes,Non-communicable diseases,Diabetes and kidney diseases,Diabetes mellitus,Type 2 diabetes mellitus,29700,23200,37200,27700,21900,34500,57400,45000,71900,0.02296,33.9% (30.0 to 38.2) *,34.2% (30.3 to 38.4) *,34.0% (30.3 to 38.1) *,765.2 (599.9 to 955.7),657.5 (518.1 to 820.8),709.6 (557.2 to 888.3),5.0% (1.9 to 8.2) *,5.0% (2.1 to 8.3) *,5.1% (2.3 to 8.1) *
234,All causes,Non-communicable diseases,Diabetes and kidney diseases,Chronic kidney disease,NA,18900,17700,20000,16900,15800,18100,35800,33700,38000,0.01432,21.9% (18.6 to 24.7) *,21.5% (18.7 to 24.1) *,21.7% (19.2 to 23.9) *,496.3 (465.5 to 524.8),411.5 (384.8 to 439.6),451.3 (424.9 to 478.3),−2.0% (−4.6 to 0.2),−2.4% (−4.6 to −0.3) *,−2.1% (−4.0 to −0.4) *
235,All causes,Non-communicable diseases,Diabetes and kidney diseases,Chronic kidney disease,Chronic kidney disease due to type 1 diabetes mellitus,1590,1280,1950,1300,1060,1560,2890,2370,3500,0.001156,18.5% (13.4 to 23.2) *,17.7% (13.3 to 22.2) *,18.2% (14.3 to 22.3) *,39.1 (31.6 to 48.0),31.3 (25.7 to 37.7),35.2 (28.9 to 42.6),−1.9% (−5.5 to 1.4),−3.4% (−6.3 to −0.4) *,−2.6% (−5.1 to −0.3) *
236,All causes,Non-communicable diseases,Diabetes and kidney diseases,Chronic kidney disease,Chronic kidney disease due to type 2 diabetes mellitus,4280,3700,4900,3840,3380,4340,8120,7120,9250,0.003248,34.2% (29.0 to 38.1) *,34.4% (31.2 to 37.6) *,34.3% (30.9 to 37.2) *,112.7 (97.7 to 128.8),90.2 (79.2 to 102.0),100.9 (88.4 to 114.8),2.0% (−1.9 to 4.6),2.4% (0.1 to 4.8) *,2.3% (−0.2 to 4.2)
237,All causes,Non-communicable diseases,Diabetes and kidney diseases,Chronic kidney disease,Chronic kidney disease due to hypertension,4050,3520,4550,3300,2900,3710,7350,6450,8220,0.00294,32.4% (27.5 to 36.2) *,32.3% (29.1 to 35.2) *,32.3% (29.0 to 35.0) *,110.2 (96.2 to 123.3),78.0 (68.6 to 87.7),92.7 (81.7 to 103.7),1.4% (−2.1 to 4.0),2.3% (−0.1 to 4.5),2.1% (−0.3 to 4.1)
238,All causes,Non-communicable diseases,Diabetes and kidney diseases,Chronic kidney disease,Chronic kidney disease due to glomerulonephritis,3570,3160,4020,3040,2680,3420,6600,5860,7420,0.00264,14.7% (11.3 to 18.0) *,12.9% (9.4 to 16.4) *,13.8% (11.0 to 17.0) *,92.3 (81.9 to 103.7),75.9 (67.1 to 84.9),83.7 (74.4 to 93.7),−3.6% (−5.9 to −1.4) *,−5.4% (−7.9 to −3) *,−4.4% (−6.3 to −2.4) *
239,All causes,Non-communicable diseases,Diabetes and kidney diseases,Chronic kidney disease,Chronic kidney disease due to other and unspecified causes,5390,4780,6060,5470,4800,6270,10900,9660,12200,0.00436,12.6% (9.2 to 16.1) *,14.0% (10.7 to 17.3) *,13.3% (10.4 to 16.2) *,142.1 (126.4 to 159.3),136.1 (119.7 to 155.0),138.8 (123.7 to 155.9),−6.3% (−8.5 to −3.8) *,−5.9% (−8.4 to −3.4) *,−6.0% (−8.0 to −4.1) *
240,All causes,Non-communicable diseases,Diabetes and kidney diseases,Acute glomerulonephritis,NA,180,165,201,130,117,145,311,285,339,1.244e-4,−3.9% (−10.5 to 7.0),−7.6% (−13.0 to 0.5),−5.5% (−10.3 to 2.2),4.7 (4.3 to 5.3),3.3 (2.9 to 3.7),4.0 (3.6 to 4.3),−19.2% (−24.8 to −10.5) *,−23.0% (−27.5 to −16.3) *,−20.9% (−25.0 to −15.0) *
241,All causes,Non-communicable diseases,Skin and subcutaneous diseases,NA,NA,20900,14200,30700,23200,15800,33500,44100,29900,64200,0.01764,13.7% (12.9 to 15.1) *,13.7% (13.0 to 14.9) *,13.7% (13.0 to 14.7) *,553.3 (375.4 to 812.0),618.0 (418.6 to 893.5),585 (396.2 to 851.8),0.9% (0.2 to 2.1) *,0.7% (0.1 to 1.5) *,0.8% (0.2 to 1.6) *
242,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Dermatitis,NA,5100,2980,8140,6020,3510,9590,11100,6480,17700,0.00444,12.3% (11.3 to 13.3) *,11.9% (11.1 to 12.8) *,12.1% (11.3 to 12.8) *,136.5 (79.3 to 217.8),164.7 (94.8 to 263.5),150.3 (87.0 to 240.3),1.4% (0.5 to 2.4) *,0.9% (0 to 1.7) *,1.1% (0.4 to 1.8) *
243,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Dermatitis,Atopic dermatitis,4100,2220,6820,4900,2670,8160,9000,4890,15000,0.0036,11.9% (10.8 to 13.0) *,11.4% (10.4 to 12.4) *,11.6% (10.8 to 12.5) *,110.7 (59.8 to 184.4),136.4 (74.0 to 227.2),123.3 (66.8 to 205.2),2.0% (0.9 to 3.2) *,1.4% (0.5 to 2.4) *,1.7% (0.9 to 2.6) *
244,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Dermatitis,Contact dermatitis,937,618,1390,1050,692,1560,1990,1300,2950,7.96e-4,14.4% (12.3 to 16.4) *,14.4% (12.5 to 16.3) *,14.4% (12.6 to 16.2) *,24.0 (15.8 to 35.6),26.6 (17.4 to 39.4),25.3 (16.6 to 37.4),−0.8% (−1.7 to 0.1),−1.3% (−2.2 to −0.5) *,−1.1% (−1.7 to −0.5) *
245,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Dermatitis,Seborrhoeic dermatitis,69,39.8,110,66.6,38.3,105,136,78.1,215,5.44e-5,8.9% (6.7 to 11.2) *,7.8% (5.6 to 10.1) *,8.4% (6.6 to 10.3) *,1.8 (1.0 to 2.8),1.7 (1.0 to 2.7),1.7 (1.0 to 2.7),−6.7% (−8.3 to −5.1) *,−7.5% (−9.0 to −5.9) *,−7.1% (−8.3 to −5.8) *
246,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Psoriasis,NA,2710,1920,3590,2860,2030,3770,5570,3960,7350,0.002228,21.2% (20.2 to 22.4) *,20.9% (19.8 to 22.0) *,21.1% (20.3 to 21.9) *,68.7 (48.7 to 90.9),71.4 (50.7 to 94.2),70.0 (49.7 to 92.5),2.5% (1.7 to 3.4) *,2.1% (1.2 to 3.0) *,2.3% (1.6 to 2.9) *
247,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Bacterial skin diseases,NA,1160,700,1590,1110,636,1540,2270,1560,2900,9.08e-4,24.2% (13.4 to 39.3) *,26.9% (17.9 to 42.0) *,25.5% (17.8 to 34.9) *,31.1 (18.7 to 42.9),29.1 (16.6 to 40.7),30.0 (20.6 to 38.2),4.6% (−4.5 to 18.1),7.2% (−1.0 to 20.4),6.0% (−0.5 to 14.5)
248,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Bacterial skin diseases,Cellulitis,321,178,465,278,155,393,598,377,760,2.392e-4,34.4% (22.9 to 48.1) *,30.1% (15.8 to 46.6) *,32.4% (26.4 to 41.1) *,8.4 (4.7 to 12.3),7.0 (3.9 to 9.8),7.7 (4.9 to 9.8),12.4% (2.7 to 24.4) *,7.5% (−3.7 to 21.6),10.0% (5.1 to 17.4) *
249,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Bacterial skin diseases,Pyoderma,843,489,1170,833,441,1190,1680,1110,2200,6.72e-4,20.6% (9.4 to 37.5) *,25.9% (16.3 to 41.7) *,23.2% (14.5 to 34.3) *,22.7 (13.1 to 31.5),22.1 (11.7 to 31.9),22.3 (14.8 to 29.4),2.0% (−7.5 to 17.2),7.1% (−1.8 to 21.3),4.7% (−2.7 to 14.7)
250,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Scabies,NA,2260,1250,3700,2270,1260,3700,4530,2510,7410,0.001812,6.4% (5.0 to 7.9) *,6.7% (5.3 to 8.2) *,6.6% (5.3 to 8.0) *,59.4 (32.9 to 96.8),60.6 (33.5 to 98.8),60.0 (33.2 to 97.8),−3.2% (−3.8 to −2.5) *,−3.1% (−3.7 to −2.5) *,−3.1% (−3.6 to −2.6) *
251,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Fungal skin diseases,NA,2100,832,4370,2050,819,4260,4150,1650,8630,0.00166,9.8% (8.1 to 11.5) *,12.1% (10.4 to 13.7) *,10.9% (9.2 to 12.5) *,56.5 (22.4 to 117.4),53.2 (21.2 to 110.5),54.9 (21.8 to 114.2),−4.6% (−5.6 to −3.6) *,−4.1% (−5.1 to −3.1) *,−4.4% (−5.4 to −3.4) *
252,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Viral skin diseases,NA,1940,1250,2880,2090,1350,3110,4030,2600,6000,0.001612,7.1% (6.4 to 7.7) *,5.9% (5.3 to 6.4) *,6.4% (6.0 to 6.9) *,52.9 (33.9 to 78.5),59.0 (38.0 to 87.7),56.0 (36.0 to 83.2),−1.0% (−1.5 to −0.4) *,−2.5% (−3.0 to −2.0) *,−1.8% (−2.2 to −1.4) *
253,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Acne vulgaris,NA,1150,677,1830,1400,841,2230,2550,1520,4060,0.00102,17.3% (15.8 to 18.9) *,15.3% (14.1 to 16.6) *,16.2% (15.2 to 17.2) *,30.0 (17.7 to 47.9),37.9 (22.7 to 60.5),33.9 (20.2 to 54.1),12.8% (11.3 to 14.6) *,10.2% (9.0 to 11.6) *,11.4% (10.3 to 12.5) *
254,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Alopecia areata,NA,241,154,358,282,181,418,523,335,775,2.092e-4,12.8% (11.3 to 14.2) *,12.7% (11.4 to 14.0) *,12.7% (11.8 to 13.8) *,6.1 (3.9 to 9.1),7.1 (4.6 to 10.6),6.6 (4.2 to 9.8),−0.6% (−1.9 to 0.7),−2.2% (−3.3 to −1.2) *,−1.5% (−2.3 to −0.6) *
255,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Pruritus,NA,331,156,632,424,200,801,756,356,1430,3.024e-4,19.3% (17.7 to 20.9) *,18.6% (17.1 to 20.2) *,18.9% (17.5 to 20.4) *,8.6 (4.0 to 16.1),10.7 (5.0 to 20.2),9.7 (4.5 to 18.2),2.2% (1.6 to 2.8) *,1.2% (0.6 to 1.7) *,1.6% (1.2 to 2.0) *
256,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Urticaria,NA,2190,1450,3090,2830,1880,3970,5010,3320,7050,0.002004,10.8% (9.6 to 12.1) *,10.8% (9.6 to 12.0) *,10.8% (9.8 to 11.9) *,58.4 (38.6 to 82.5),77.2 (51.1 to 109.0),67.7 (44.8 to 95.4),0.6% (−0.2 to 1.5),0.1% (−0.5 to 0.8),0.3% (−0.2 to 0.8)
257,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Decubitus ulcer,NA,238,169,357,265,184,371,503,379,661,2.012e-4,26.2% (18.8 to 41.0) *,28.1% (21.7 to 35.5) *,27.2% (21.5 to 37.7) *,6.7 (4.7 to 10.1),6.3 (4.4 to 8.9),6.5 (4.9 to 8.6),−2.3% (−8.2 to 9.4),−0.8% (−5.9 to 5.6),−1.6% (−6.0 to 7.1)
258,All causes,Non-communicable diseases,Skin and subcutaneous diseases,Other skin and subcutaneous diseases,NA,1470,736,2680,1640,819,2970,3110,1560,5650,0.001244,25.8% (25.0 to 26.5) *,25.0% (24.2 to 26.0) *,25.4% (24.8 to 26.0) *,38.4 (19.3 to 69.9),40.7 (20.4 to 73.9),39.5 (19.8 to 71.9),4.5% (3.9 to 5.0) *,3.9% (3.3 to 4.7) *,4.2% (3.8 to 4.7) *
259,All causes,Non-communicable diseases,Sense organ diseases,NA,NA,31700,21300,45700,34800,23500,49900,66600,44700,95700,0.02664,23.9% (23.1 to 24.9) *,24.2% (23.4 to 25.0) *,24.1% (23.4 to 24.8) *,843.1 (568.7 to 1205.8),841.0 (567.7 to 1206.4),842.2 (566.6 to 1206.5),−0.9% (−1.7 to −0.3) *,−0.9% (−1.6 to −0.2) *,−0.9% (−1.5 to −0.3) *
260,All causes,Non-communicable diseases,Sense organ diseases,Blindness and vision impairment,NA,13500,9060,20000,16400,11100,24100,29900,20300,44000,0.01196,23.6% (22.4 to 24.8) *,22.6% (21.6 to 23.5) *,23.1% (22.0 to 24) *,356.2 (240.0 to 523.0),395.7 (267.6 to 583.1),376.6 (255.6 to 555),−1.5% (−2.4 to −0.6) *,−2.1% (−3 to −1.2) *,−1.8% (−2.7 to −0.9) *
261,All causes,Non-communicable diseases,Sense organ diseases,Blindness and vision impairment,Glaucoma,342,230,474,344,233,478,686,463,949,2.744e-4,28.8% (27.0 to 30.8) *,27.1% (25.1 to 28.9) *,27.9% (26.4 to 29.4) *,9.4 (6.3 to 12.9),8.0 (5.4 to 11.2),8.6 (5.8 to 12.0),−4.7% (−6.1 to −3.4) *,−4.8% (−6.3 to −3.3) *,−4.7% (−5.8 to −3.6) *
262,All causes,Non-communicable diseases,Sense organ diseases,Blindness and vision impairment,Cataract,3350,2340,4540,4650,3250,6270,8010,5580,10800,0.003204,31.3% (28.5 to 34.1) *,28.4% (26.5 to 30.2) *,29.6% (27.4 to 31.7) *,93.2 (65.1 to 126.4),109.0 (76 to 147),101.8 (70.9 to 137.7),−1.7% (−3.7 to 0.2),−2.3% (−3.7 to −0.9) *,−2.0% (−3.6 to −0.5) *
263,All causes,Non-communicable diseases,Sense organ diseases,Blindness and vision impairment,Age-related macular degeneration,223,153,307,308,210,422,531,364,729,2.124e-4,34.1% (31.3 to 37.1) *,28.3% (26.2 to 30.6) *,30.7% (28.6 to 32.9) *,6.3 (4.3 to 8.6),7.2 (4.9 to 9.8),6.8 (4.6 to 9.3),−1.4% (−3.2 to 0.6),−4.8% (−6.5 to −3.1) *,−3.7% (−5.3 to −2.1) *
264,All causes,Non-communicable diseases,Sense organ diseases,Blindness and vision impairment,Refraction disorders,3980,2650,5780,4000,2700,5720,7980,5350,11500,0.003192,17.0% (15.0 to 19.0) *,13.7% (12.0 to 15.2) *,15.3% (13.6 to 17.0) *,103.8 (68.9 to 150.7),100.7 (67.6 to 144.2),102.2 (68.2 to 147.3),−1.5% (−2.9 to −0.1) *,−4.6% (−5.7 to −3.6) *,−3.1% (−4.2 to −1.9) *
265,All causes,Non-communicable diseases,Sense organ diseases,Blindness and vision impairment,Near vision loss,4260,2030,7790,5540,2640,10100,9800,4670,17900,0.00392,23.7% (22.9 to 24.5) *,25.4% (24.6 to 26.1) *,24.6% (24 to 25.2) *,108.3 (51.7 to 198.2),133.7 (63.6 to 244.5),121.0 (57.7 to 221.3),−0.7% (−1.2 to −0.2) *,1.4% (0.9 to 1.9) *,0.5% (0.1 to 0.9) *
266,All causes,Non-communicable diseases,Sense organ diseases,Blindness and vision impairment,Other vision loss,1350,941,1810,1540,1070,2070,2890,2010,3880,0.001156,22.9% (20.9 to 24.7) *,19.5% (17.8 to 21.1) *,21.0% (19.4 to 22.6) *,35.3 (24.6 to 47.5),37.1 (25.8 to 49.9),36.3 (25.3 to 48.9),−2.1% (−3.5 to −0.8) *,−5.0% (−6.1 to −3.9) *,−3.7% (−4.8 to −2.6) *
267,All causes,Non-communicable diseases,Sense organ diseases,Age-related and other hearing loss,NA,17200,11500,24500,17100,11600,24200,34200,23200,48700,0.01368,24.2% (22.8 to 25.6) *,25.7% (24.4 to 27.1) *,24.9% (23.9 to 26.0) *,458.7 (311.5 to 650.0),411.6 (279.5 to 583.7),434.6 (295.4 to 616.1),−0.7% (−1.8 to 0.4),0.2% (−0.9 to 1.2),−0.2% (−1.0 to 0.5)
268,All causes,Non-communicable diseases,Sense organ diseases,Other sense organ diseases,NA,1070,665,1570,1380,854,2010,2450,1520,3570,9.8e-4,24.9% (23.9 to 26.0) *,25.0% (24.1 to 26) *,25.0% (24.2 to 25.8) *,28.1 (17.5 to 41.2),33.7 (20.9 to 49.0),31.0 (19.2 to 45.2),1.1% (0.4 to 1.8) *,0.8% (0.1 to 1.5) *,0.9% (0.4 to 1.4) *
269,All causes,Non-communicable diseases,Musculoskeletal disorders,NA,NA,60800,44700,80400,77900,57500,103000,139000,102000,183000,0.0556,19.5% (18.3 to 20.7) *,20.2% (19 to 21.6) *,19.9% (18.8 to 21.2) *,1538.9 (1134.0 to 2023.2),1894.7 (1398.6 to 2491.4),1720.5 (1264.4 to 2259.2),−1% (−1.7 to −0.4) *,−1.2% (−1.9 to −0.5) *,−1.1% (−1.7 to −0.5) *
270,All causes,Non-communicable diseases,Musculoskeletal disorders,Rheumatoid arthritis,NA,977,750,1220,2510,1910,3180,3490,2660,4410,0.001396,26.1% (22.9 to 28.9) *,30.6% (26.3 to 34.1) *,29.3% (26.0 to 32.1) *,25.4 (19.6 to 31.5),60.1 (45.5 to 76.0),43.3 (33.0 to 54.5),−0.6% (−3.5 to 1.7),3.4% (0.1 to 6.2) *,2.3% (−0.5 to 4.6)
271,All causes,Non-communicable diseases,Musculoskeletal disorders,Osteoarthritis,NA,3840,1930,7680,5760,2880,11500,9600,4810,19100,0.00384,32.0% (31.0 to 33.0) *,31.0% (30.3 to 31.8) *,31.4% (30.7 to 32.1) *,100.0 (50.3 to 199.1),135.6 (67.7 to 269.7),118.8 (59.5 to 236.2),1.6% (0.9 to 2.3) *,0.8% (0.2 to 1.4) *,1.0% (0.5 to 1.6) *
272,All causes,Non-communicable diseases,Musculoskeletal disorders,Low back pain,NA,29500,21000,40000,35500,25400,47700,64900,46500,87400,0.02596,17.8% (16.5 to 19.3) *,17.3% (15.8 to 18.8) *,17.5% (16.2 to 19.0) *,748.2 (537.6 to 1008.5),869.1 (624.5 to 1164.5),810.3 (582.4 to 1089.1),−1.3% (−1.9 to −0.7) *,−2.7% (−3.3 to −2.2) *,−2.1% (−2.6 to −1.6) *
273,All causes,Non-communicable diseases,Musculoskeletal disorders,Neck pain,NA,12200,8540,17200,16400,11400,22900,28600,20000,40200,0.01144,22.3% (20.1 to 24.3) *,20.8% (18.4 to 23.7) *,21.4% (19.5 to 23.6) *,307.4 (215.7 to 430.8),395.1 (275.9 to 551.8),352.0 (245.6 to 493.3),0.4% (−0.8 to 1.5),−1.5% (−3.0 to 0.2),−0.7% (−1.6 to 0.5)
274,All causes,Non-communicable diseases,Musculoskeletal disorders,Gout,NA,953,641,1300,332,226,451,1280,867,1770,5.12e-4,30.2% (28.2 to 32.2) *,32.9% (30.5 to 35.3) *,30.9% (29.2 to 32.6) *,24.6 (16.6 to 33.8),7.8 (5.3 to 10.7),15.9 (10.7 to 21.8),2.4% (1.1 to 3.7) *,3.1% (1.3 to 4.9) *,2.7% (1.6 to 3.7) *
275,All causes,Non-communicable diseases,Musculoskeletal disorders,Other musculoskeletal disorders,NA,13300,9130,18400,17500,12400,23600,30800,21500,42000,0.01232,16.6% (13.2 to 19.8) *,21.0% (17.7 to 24.4) *,19.1% (15.8 to 22.3) *,333.3 (229.5 to 459.1),427.0 (303.1 to 577.3),380.2 (266.2 to 520.3),−2.7% (−5.2 to −0.4) *,0.9% (−1.6 to 3.2),−0.7% (−3.0 to 1.4)
276,All causes,Non-communicable diseases,Other non-communicable diseases,NA,NA,56000,48900,64900,65900,54700,79500,122000,104000,144000,0.0488,−3.8% (−10.8 to 0.6),0.3% (−3.7 to 3.3),−1.6% (−6.1 to 1.6),1547.8 (1362.6 to 1778.5),1812.4 (1524.5 to 2156.7),1678.1 (1450.0 to 1961.2),−12.8% (−18.8 to −9.3) *,−10.3% (−13.4 to −7.9) *,−11.5% (−15.4 to −8.9) *
277,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,NA,32300,29800,35300,28600,26400,30700,60900,56400,65400,0.02436,−12.1% (−21.3 to −7.0) *,−9.6% (−14.8 to −5.7) *,−10.9% (−17.3 to −7.1) *,917.1 (847.3 to 999.7),859.6 (795.0 to 920.4),889.0 (827.6 to 951.5),−16.7% (−25.3 to −12) *,−14.8% (−19.6 to −11) *,−15.8% (−21.8 to −12.3) *
278,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Neural tube defects,3140,2380,4350,3030,2280,4150,6170,4840,8170,0.002468,−11.2% (−27.1 to 1.4),−9.0% (−22.0 to 4.9),−10.2% (−21.3 to 0.9),90.1 (68.3 to 125.1),92.7 (69.7 to 127.2),91.3 (71.7 to 121.2),−15.3% (−30.4 to −3.2) *,−13.6% (−26.0 to −0.2) *,−14.5% (−25.1 to −4.0) *
279,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Congenital heart anomalies,11500,9480,14000,10700,8260,12600,22200,18400,26300,0.00888,−19.1% (−27.9 to −9.6) *,−17.6% (−23.4 to −10.1) *,−18.4% (−24.8 to −10.3) *,332.1 (272.0 to 404.0),328.0 (253.0 to 388.2),330.0 (272.3 to 390.8),−22.5% (−30.9 to −13.4) *,−21.3% (−26.9 to −14.2) *,−21.9% (−28.1 to −14.3) *
280,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Orofacial clefts,352,194,657,300,187,599,652,411,1110,2.608e-4,−21.9% (−37.7 to −4.3) *,−21.8% (−38.2 to −5.6) *,−21.9% (−35.2 to −8.1) *,9.8 (5.3 to 18.7),8.7 (5.3 to 18.2),9.3 (5.8 to 16.2),−27.2% (−41.8 to −10.0) *,−28.3% (−42.6 to −13.9) *,−27.7% (−39.9 to −15.4) *
281,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Down syndrome,1240,963,1790,989,755,1520,2230,1760,3040,8.92e-4,−1.5% (−12.1 to 14.2),2.6% (−9.0 to 16.7),0.3% (−9.2 to 13.6),34.8 (26.7 to 50.5),29.0 (21.9 to 45.3),32.0 (24.9 to 43.9),−7.8% (−17.4 to 6.7),−4.6% (−15.3 to 8.3),−6.4% (−15.1 to 5.9)
282,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Turner syndrome,NA,NA,NA,10.1,5.02,16.5,10.1,5.02,16.5,4.0399999999999994e-6,NA,9.1% (7.3 to 10.9) *,9.1% (7.3 to 10.9) *,NA,0.3 (0.1 to 0.5),0.1 (0.1 to 0.2),NA,1.0% (−0.6 to 2.6),0.9% (−0.7 to 2.5)
283,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Klinefelter syndrome,5.16,2.43,9.74,NA,NA,NA,5.16,2.43,9.74,2.064e-6,7.4% (4.3 to 10.7) *,NA,7.4% (4.3 to 10.7) *,0.1 (0.1 to 0.3),NA,0.1 (0 to 0.1),−1.9% (−4.7 to 1.0),NA,−1.7% (−4.5 to 1.1)
284,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Other chromosomal abnormalities,928,654,1380,1170,769,2010,2100,1510,2840,8.4e-4,10.2% (−2.8 to 22.0),6.1% (−7.2 to 19.3),7.9% (−1.9 to 18.2),26.0 (18.3 to 38.8),35.2 (22.6 to 61.2),30.4 (21.8 to 41.3),3.7% (−8.1 to 14.5),0.2% (−11.8 to 12.6),1.7% (−7.2 to 11.4)
285,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Congenital musculoskeletal and limb anomalies,2890,2030,3790,2650,1850,3510,5530,3880,7270,0.002212,8.6% (4.1 to 11.8) *,9.0% (4.2 to 12.8) *,8.8% (4.8 to 11.1) *,76.8 (54.5 to 100.5),71.6 (50.4 to 94.3),74.2 (52.6 to 97.2),−2.3% (−5.9 to 0.3),−2.7% (−6.7 to 0.4),−2.5% (−5.6 to −0.5) *
286,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Urogenital congenital anomalies,687,459,879,560,411,698,1250,926,1500,5e-4,−4.9% (−15.5 to 8.5),−3.9% (−13.3 to 7.3),−4.5% (−13.2 to 6.1),19.7 (13.0 to 25.3),16.9 (12.3 to 21.0),18.3 (13.6 to 22.1),−9.1% (−19.1 to 3.5),−9.1% (−18.1 to 1.8),−9.1% (−17.2 to 0.8)
287,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Digestive congenital anomalies,2970,2190,3960,2220,1440,3300,5190,3990,7050,0.002076,−16.1% (−30.4 to −4.8) *,−9.5% (−17.8 to 1.3),−13.4% (−24.5 to −4.0) *,85.3 (62.6 to 113.9),67.5 (43.1 to 101.0),76.7 (58.7 to 104.6),−20.0% (−33.4 to −9.1) *,−14.1% (−21.9 to −4.1) *,−17.6% (−28.1 to −8.9) *
288,All causes,Non-communicable diseases,Other non-communicable diseases,Congenital anomalies,Other congenital anomalies,8570,6620,10500,6980,5170,8960,15500,12000,19200,0.0062,−9.7% (−17.9 to 1.5),−5.8% (−14.8 to 5.0),−8.0% (−15.8 to 2.7),242.4 (186.3 to 297.7),209.8 (155.1 to 270.2),226.5 (174.1 to 279.7),−14.5% (−22.1 to −4.1) *,−11.0% (−19.4 to −1.0) *,−13.0% (−20.4 to −3.3) *
289,All causes,Non-communicable diseases,Other non-communicable diseases,Urinary diseases and male infertility,NA,6080,5080,7320,3310,3140,3480,9390,8260,10700,0.003756,21.8% (18.1 to 25.1) *,24.5% (18 to 28.2) *,22.8% (18.9 to 25.6) *,162.2 (136 to 194.8),82.7 (78.4 to 87.1),119.9 (105.9 to 136.8),−2.7% (−5.3 to −0.2) *,2.3% (−3.3 to 5.4),−0.8% (−3.9 to 1.6)
290,All causes,Non-communicable diseases,Other non-communicable diseases,Urinary diseases and male infertility,Urinary tract infections,2120,1970,2410,2570,2410,2830,4700,4430,5190,0.00188,24.5% (17.7 to 31.7) *,36.4% (28.5 to 44.1) *,30.8% (24.2 to 37.8) *,57.8 (53.8 to 65.4),63.8 (59.5 to 70.5),60.7 (57.2 to 67.2),2.3% (−3.0 to 7.9),11.3% (4.8 to 17.6) *,7.0% (1.6 to 12.6) *
291,All causes,Non-communicable diseases,Other non-communicable diseases,Urinary diseases and male infertility,Urolithiasis,281,227,346,205,165,252,486,397,591,1.944e-4,15.9% (9.5 to 25.0) *,23.7% (18.2 to 34.5) *,19.1% (13.6 to 28) *,7.3 (5.9 to 8.9),4.9 (4.0 to 6.1),6.0 (4.9 to 7.3),−7.0% (−12.3 to 0.3),−0.2% (−4.6 to 8.2),−4.1% (−8.5 to 3.0)
292,All causes,Non-communicable diseases,Other non-communicable diseases,Urinary diseases and male infertility,Benign prostatic hyperplasia,2430,1560,3460,NA,NA,NA,2430,1560,3460,9.72e-4,32.0% (30.7 to 33.3) *,NA,32.0% (30.7 to 33.3) *,63.7 (40.9 to 90.7),NA,29.9 (19.2 to 42.5),−0.7% (−1.6 to 0.3),NA,−0.2% (−1.1 to 0.8)
293,All causes,Non-communicable diseases,Other non-communicable diseases,Urinary diseases and male infertility,Male infertility,181,74.8,374,NA,NA,NA,181,74.8,374,7.24e-5,17.0% (13.7 to 20.1) *,NA,17.0% (13.7 to 20.1) *,4.6 (1.9 to 9.5),NA,2.3 (1.0 to 4.8),6.7% (3.9 to 9.4) *,NA,6.9% (4.1 to 9.7) *
294,All causes,Non-communicable diseases,Other non-communicable diseases,Urinary diseases and male infertility,Other urinary diseases,1080,903,1240,526,346,654,1600,1290,1790,6.4e-4,1.7% (−6.3 to 11.6),−12.4% (−23.3 to −3.3) *,−3.4% (−9.4 to 5.1),28.9 (24.3 to 33.4),13.9 (9.2 to 17.4),21.0 (16.9 to 23.6),−15.0% (−21.4 to −7.3) *,−24.8% (−33.4 to −17.3) *,−18.4% (−23.1 to −11.5) *
295,All causes,Non-communicable diseases,Other non-communicable diseases,Gynaecological diseases,NA,NA,NA,NA,11900,8210,16600,11900,8210,16600,0.00476,NA,10.2% (9.0 to 11.6) *,10.2% (9.0 to 11.6) *,NA,299.4 (206.4 to 415.8),148.8 (102.6 to 206.6),NA,−2.4% (−3.3 to −1.4) *,−2.5% (−3.4 to −1.4) *
296,All causes,Non-communicable diseases,Other non-communicable diseases,Gynaecological diseases,Uterine fibroids,NA,NA,NA,1550,947,2460,1550,947,2460,6.2e-4,NA,8.3% (4.5 to 11.9) *,8.3% (4.5 to 11.9) *,NA,37.7 (23.1 to 59.9),18.9 (11.5 to 30.0),NA,−8.2% (−11.4 to −5.2) *,−7.9% (−11.1 to −5.0) *
297,All causes,Non-communicable diseases,Other non-communicable diseases,Gynaecological diseases,Polycystic ovarian syndrome,NA,NA,NA,460,204,886,460,204,886,1.84e-4,NA,13.1% (12.1 to 14.0) *,13.1% (12.1 to 14.0) *,NA,11.7 (5.2 to 22.7),5.8 (2.6 to 11.2),NA,2.0% (1.1 to 2.8) *,1.8% (1.0 to 2.7) *
298,All causes,Non-communicable diseases,Other non-communicable diseases,Gynaecological diseases,Female infertility,NA,NA,NA,343,129,723,343,129,723,1.372e-4,NA,27.5% (22.2 to 32.7) *,27.5% (22.2 to 32.7) *,NA,8.8 (3.3 to 18.5),4.4 (1.7 to 9.2),NA,16.7% (12.2 to 21.1) *,16.5% (12.0 to 20.8) *
299,All causes,Non-communicable diseases,Other non-communicable diseases,Gynaecological diseases,Endometriosis,NA,NA,NA,4130,2760,5950,4130,2760,5950,0.001652,NA,9.2% (7.9 to 10.5) *,9.2% (7.9 to 10.5) *,NA,103.9 (69.5 to 149.1),51.6 (34.5 to 74),NA,−2.9% (−3.8 to −1.9) *,−3.0% (−3.9 to −2.0) *
300,All causes,Non-communicable diseases,Other non-communicable diseases,Gynaecological diseases,Genital prolapse,NA,NA,NA,352,173,652,352,173,652,1.408e-4,NA,18.6% (16.0 to 20.4) *,18.6% (16.0 to 20.4) *,NA,8.4 (4.1 to 15.6),4.3 (2.1 to 8.0),NA,−4.5% (−6.7 to −3.4) *,−4.7% (−6.9 to −3.5) *
301,All causes,Non-communicable diseases,Other non-communicable diseases,Gynaecological diseases,Premenstrual syndrome,NA,NA,NA,3930,2530,5900,3930,2530,5900,0.001572,NA,8.8% (7.2 to 10.1) *,8.8% (7.2 to 10.1) *,NA,100.0 (64.5 to 150.1),49.5 (31.9 to 74.3),NA,−2.1% (−3.5 to −0.9) *,−2.2% (−3.6 to −1.0) *
302,All causes,Non-communicable diseases,Other non-communicable diseases,Gynaecological diseases,Other gynaecological diseases,NA,NA,NA,1150,830,1580,1150,830,1580,4.6e-4,NA,13.5% (10.1 to 16.6) *,13.5% (10.1 to 16.6) *,NA,28.9 (20.8 to 39.6),14.4 (10.3 to 19.7),NA,0.2% (−2.8 to 3.0),0.2% (−2.8 to 3.0)
303,All causes,Non-communicable diseases,Other non-communicable diseases,Haemoglobinopathies and haemolytic anaemias,NA,4350,3040,6130,5800,4510,7370,10100,7740,13300,0.00404,−1.0% (−9.7 to 7.3),−5.6% (−10.3 to 0.2),−3.7% (−9.3 to 2.3),117.9 (82.4 to 165.8),156.6 (122.3 to 198.9),137.1 (104.6 to 179.3),−10.5% (−18.6 to −2.8) *,−15.3% (−19.8 to −9.8) *,−13.2% (−18.5 to −7.6) *
304,All causes,Non-communicable diseases,Other non-communicable diseases,Haemoglobinopathies and haemolytic anaemias,Thalassaemias,308,239,367,274,221,338,582,491,683,2.328e-4,−21.1% (−33.6 to −6.2) *,−28.0% (−36.5 to −13.4) *,−24.5% (−33.5 to −13.4) *,8.7 (6.8 to 10.4),8.2 (6.6 to 10.1),8.4 (7.1 to 9.9),−25% (−37.2 to −10.7) *,−32.0% (−40.2 to −18.0) *,−28.5% (−37.2 to −17.8) *
305,All causes,Non-communicable diseases,Other non-communicable diseases,Haemoglobinopathies and haemolytic anaemias,Thalassaemias trait,477,306,722,1430,968,2070,1910,1280,2780,7.64e-4,−13.8% (−20.0 to −7.0) *,−11.5% (−16 to −6.8) *,−12.1% (−16.1 to −7.7) *,12.8 (8.2 to 19.3),37.2 (25.1 to 53.8),25 (16.8 to 36.4),−22.6% (−28.1 to −16.8) *,−21.4% (−25.4 to −17.3) *,−21.6% (−25.1 to −18.0) *
306,All causes,Non-communicable diseases,Other non-communicable diseases,Haemoglobinopathies and haemolytic anaemias,Sickle cell disorders,1580,865,2640,1470,1050,2090,3050,2000,4200,0.00122,8.2% (−11.4 to 23.1),−1.9% (−15.7 to 19.2),3.1% (−11.6 to 16.9),43.5 (23.8 to 72.8),42.9 (30.6 to 61.2),43.2 (28.3 to 59.4),2.2% (−16.6 to 16.6),−8.1% (−21.4 to 12.7),−3.0% (−16.9 to 10.6)
307,All causes,Non-communicable diseases,Other non-communicable diseases,Haemoglobinopathies and haemolytic anaemias,Sickle cell trait,362,237,534,841,567,1200,1200,812,1730,4.8e-4,−5.1% (−13.0 to 3.5),0.4% (−3.4 to 4.4),−1.3% (−5.1 to 2.9),9.8 (6.4 to 14.6),22.8 (15.4 to 32.5),16.3 (11.0 to 23.4),−13.4% (−20.4 to −5.4) *,−8.8% (−12.3 to −5.2) *,−10.3% (−13.9 to −6.4) *
308,All causes,Non-communicable diseases,Other non-communicable diseases,Haemoglobinopathies and haemolytic anaemias,G6PD deficiency,485,330,655,232,187,289,717,546,920,2.868e-4,6.6% (−2.1 to 16.1),−0.3% (−5.6 to 8.2),4.3% (−2.2 to 11.9),12.3 (8.4 to 16.6),5.9 (4.8 to 7.4),9.1 (7.0 to 11.7),−7.8% (−14.3 to −0.5) *,−13.0% (−17.7 to −5.4) *,−9.6% (−14.7 to −3.5) *
309,All causes,Non-communicable diseases,Other non-communicable diseases,Haemoglobinopathies and haemolytic anaemias,G6PD trait,0,0,0,0.416,0.281,0.58,0.416,0.281,0.58,1.6639999999999998e-7,NA,3.0% (−1.7 to 7.8),3.0% (−1.7 to 7.8),0 (0 to 0),0 (0 to 0),0 (0 to 0),NA,−8.1% (−12.1 to −3.9) *,−8.1% (−12.2 to −3.9) *
310,All causes,Non-communicable diseases,Other non-communicable diseases,Haemoglobinopathies and haemolytic anaemias,Other haemoglobinopathies and haemolytic anaemias,1140,845,1550,1550,1180,2060,2680,2030,3580,0.001072,−1.2% (−5.5 to 3.8),−1.6% (−4.1 to 1.0),−1.4% (−3.8 to 1.4),30.7 (22.9 to 41.6),39.4 (29.9 to 52.8),35.0 (26.4 to 46.7),−15.3% (−19.2 to −11) *,−15.9% (−18.4 to −13.6) *,−15.6% (−18.1 to −12.9) *
311,All causes,Non-communicable diseases,Other non-communicable diseases,"Endocrine, metabolic, blood, and immune disorders",NA,3310,2750,3820,4410,3610,5350,7720,6500,9080,0.003088,10.3% (3.9 to 15.5) *,5.1% (1.6 to 8.5) *,7.3% (3.0 to 11.1) *,89.1 (73.8 to 102.7),115.1 (94.0 to 140.0),101.8 (85.9 to 120.0),−4.7% (−9.8 to −0.5) *,−9.0% (−11.8 to −6.0) *,−7.2% (−10.7 to −4.1) *
312,All causes,Non-communicable diseases,Other non-communicable diseases,Oral disorders,NA,7860,4620,12300,10400,6390,16000,18300,11000,28300,0.00732,20.5% (19.6 to 21.4) *,22.1% (21.2 to 23.0) *,21.4% (20.5 to 22.3) *,202.1 (119.1 to 315.7),253.7 (154.8 to 388.5),228.8 (137.5 to 353.7),−1.8% (−2.6 to −1.1) *,−0.9% (−1.6 to −0.2) *,−1.3% (−2.0 to −0.6) *
313,All causes,Non-communicable diseases,Other non-communicable diseases,Oral disorders,Caries of deciduous teeth,72.4,30.9,145,66.5,28.5,133,139,59.4,278,5.56e-5,4.6% (2.7 to 6.3) *,5.1% (3.0 to 6.9) *,4.9% (3.1 to 6.3) *,2.1 (0.9 to 4.1),2.0 (0.9 to 4.0),2.0 (0.9 to 4.1),−2.2% (−3.9 to −0.6) *,−2.0% (−3.9 to −0.4) *,−2.1% (−3.7 to −0.8) *
314,All causes,Non-communicable diseases,Other non-communicable diseases,Oral disorders,Caries of permanent teeth,785,338,1490,834,362,1590,1620,698,3090,6.48e-4,9.4% (8.5 to 10.4) *,9.5% (8.5 to 10.5) *,9.4% (8.6 to 10.3) *,20.0 (8.6 to 38.0),21.3 (9.2 to 40.4),20.7 (8.9 to 39.2),−3.9% (−4.7 to −3.0) *,−4.1% (−5.0 to −3.3) *,−4.0% (−4.8 to −3.3) *
315,All causes,Non-communicable diseases,Other non-communicable diseases,Oral disorders,Periodontal diseases,2470,967,5070,2720,1080,5580,5190,2040,10700,0.002076,25.1% (23.5 to 26.6) *,27.9% (26.3 to 29.3) *,26.6% (25.1 to 27.9) *,61.6 (24.2 to 127.0),65.4 (25.9 to 134.2),63.5 (25.0 to 130.3),1.8% (1.3 to 2.3) *,3.6% (3.0 to 4.3) *,2.8% (2.3 to 3.2) *
316,All causes,Non-communicable diseases,Other non-communicable diseases,Oral disorders,Edentulism and severe tooth loss,2770,1850,3940,4580,3060,6480,7350,4890,10400,0.00294,24.0% (23.1 to 24.8) *,25.1% (24.0 to 26.2) *,24.6% (23.7 to 25.5) *,73.5 (49.1 to 104.2),108.0 (72.2 to 153.1),91.7 (61.3 to 129.9),−5.1% (−5.8 to −4.4) *,−3.3% (−3.9 to −2.5) *,−4.1% (−4.7 to −3.4) *
317,All causes,Non-communicable diseases,Other non-communicable diseases,Oral disorders,Other oral disorders,1770,1100,2620,2250,1400,3310,4020,2510,5900,0.001608,15.5% (14.7 to 16.3) *,15.8% (15.0 to 16.6) *,15.7% (15 to 16.3) *,44.8 (28.0 to 66.7),56.9 (35.6 to 83.8),50.9 (31.8 to 74.7),0.3% (−0.2 to 0.7),0.2% (−0.3 to 0.6),0.2% (−0.1 to 0.5)
318,All causes,Non-communicable diseases,Other non-communicable diseases,Sudden infant death syndrome,NA,2040,816,3870,1450,572,3230,3490,1570,6730,0.001396,−18.1% (−32.9 to 2.1),−16.1% (−30.7 to 6.4),−17.3% (−28.6 to −1.4) *,59.4 (23.8 to 112.8),45.4 (17.8 to 100.9),52.7 (23.7 to 101.5),−20.9% (−35.2 to −1.4) *,−19.2% (−33.2 to 2.5),−20.2% (−31.2 to −4.9) *
319,All causes,Injuries,NA,NA,NA,171000,161000,182000,81900,74500,90000,252000,236000,271000,0.1008,−1.8% (−3.6 to 0.2),0.7% (−1.9 to 3.4),−1.0% (−2.8 to 1.0),4397.9 (4149.6 to 4678.6),2128.2 (1943.4 to 2330.6),3267.0 (3058.2 to 3505.1),−13.5% (−15.1 to −11.8) *,−12.7% (−14.7 to −10.6) *,−13.3% (−14.7 to −11.7) *
320,All causes,Injuries,Transport injuries,NA,NA,54900,52000,57800,20400,18700,22300,75300,71000,79800,0.03012,−6.0% (−8.7 to −3.2) *,−3.3% (−6.1 to −0.3) *,−5.3% (−7.7 to −2.8) *,1403.5 (1328.7 to 1475.7),528.6 (484.5 to 575.5),967.6 (914.2 to 1023.9),−16.8% (−19.1 to −14.5) *,−15.9% (−18.3 to −13.4) *,−16.6% (−18.5 to −14.6) *
321,All causes,Injuries,Transport injuries,Road injuries,NA,49800,47300,52100,18000,16600,19400,67800,64300,71500,0.02712,−6.5% (−9.3 to −3.6) *,−4.8% (−7.8 to −1.9) *,−6.1% (−8.5 to −3.5) *,1272.2 (1209.4 to 1331.3),467.2 (431.8 to 501.5),871.1 (827.9 to 917.3),−17.3% (−19.6 to −14.8) *,−17.2% (−19.7 to −14.7) *,−17.2% (−19.2 to −15.1) *
322,All causes,Injuries,Transport injuries,Road injuries,Pedestrian road injuries,16500,15200,18500,7090,6430,7870,23600,22000,25800,0.00944,−12.3% (−17.1 to −7.7) *,−11.2% (−15.0 to −6.8) *,−12.0% (−15.6 to −8.3) *,423.2 (390.0 to 474.3),184.9 (167.7 to 204.9),304.1 (283.9 to 332.1),−23.0% (−27 to −19.1) *,−23.2% (−26.5 to −19.3) *,−23.1% (−26.1 to −20.0) *
323,All causes,Injuries,Transport injuries,Road injuries,Cyclist road injuries,3290,2740,3790,1270,1050,1510,4550,3860,5270,0.00182,8.6% (2.2 to 14.9) *,12.3% (6.8 to 17.3) *,9.6% (4.2 to 14.9) *,83.5 (69.6 to 96.5),31.5 (26.2 to 37.6),57.5 (48.8 to 66.3),−6.4% (−11.8 to −0.9) *,−5.6% (−9.9 to −1.4) *,−6.3% (−10.8 to −1.7) *
324,All causes,Injuries,Transport injuries,Road injuries,Motorcyclist road injuries,11700,10300,12600,2310,1960,2610,14000,12300,15100,0.0056,−1.8% (−8.5 to 3.2),−0.1% (−7.8 to 10.0),−1.6% (−7.6 to 3.2),295.8 (259.7 to 318.9),59.0 (50.2 to 66.6),177.9 (157.3 to 191.9),−12.1% (−17.8 to −7.8) *,−12.8% (−19.4 to −4.4) *,−12.2% (−17.3 to −8.1) *
325,All causes,Injuries,Transport injuries,Road injuries,Motor vehicle road injuries,17700,16500,19000,6850,6230,7410,24600,23100,26000,0.00984,−6.5% (−9.8 to −1.7) *,−3.7% (−7.1 to 1.9),−5.7% (−8.4 to −1.3) *,453.4 (423.2 to 485.8),179.5 (162.8 to 193.5),317.2 (297.9 to 335.1),−16.6% (−19.5 to −12.2) *,−15.0% (−18.1 to −9.9) *,−16.1% (−18.4 to −12.1) *
326,All causes,Injuries,Transport injuries,Road injuries,Other road injuries,640,540,761,491,380,629,1130,932,1380,4.52e-4,1.7% (−5.2 to 17),30.2% (22.0 to 40.2) *,12.4% (5.3 to 25.6) *,16.3 (13.8 to 19.4),12.3 (9.6 to 15.6),14.3 (11.9 to 17.4),−11.8% (−17.3 to 1.4),10.1% (3.7 to 18.4) *,−3.5% (−9.1 to 7.7)
327,All causes,Injuries,Transport injuries,Other transport injuries,NA,5130,4510,5920,2400,1940,2960,7530,6480,8760,0.003012,−0.2% (−4.6 to 4.8),10.0% (5.6 to 14.3) *,2.9% (−1.0 to 6.7),131.3 (115.3 to 151.4),61.3 (49.7 to 75.3),96.5 (83.0 to 112.1),−12.1% (−15.9 to −7.9) *,−5.3% (−9.1 to −1.6) *,−10.0% (−13.3 to −6.7) *
328,All causes,Injuries,Unintentional injuries,NA,NA,65300,58800,72800,40700,35400,46700,106000,94200,119000,0.0424,−5.0% (−8.1 to −1.5) *,2.3% (−1.6 to 6.3),−2.3% (−5.4 to 1.3),1715.6 (1548.7 to 1908.9),1058.9 (924.2 to 1207.6),1389.0 (1241.3 to 1560.2),−17% (−19.5 to −14.3) *,−13% (−16.0 to −9.8) *,−15.6% (−18.0 to −12.7) *
329,All causes,Injuries,Unintentional injuries,Falls,NA,21000,17600,24900,15000,12300,18000,35900,30200,42900,0.01436,15.3% (10.3 to 20.3) *,24.4% (20.7 to 27.5) *,18.9% (15.4 to 22.7) *,549.9 (462.2 to 652.6),367.2 (304.1 to 442.2),459.4 (387.1 to 547.5),−3.8% (−7.7 to 0.4),0.3% (−2.9 to 2.8),−2.3% (−5.0 to 0.7)
330,All causes,Injuries,Unintentional injuries,Drowning,NA,11600,11100,12100,5110,4680,5510,16700,15900,17500,0.00668,−25.0% (−28.0 to −21.8) *,−27.8% (−32.5 to −20.3) *,−25.9% (−28.8 to −22.2) *,311.4 (298.2 to 325.9),145.9 (133.3 to 158.3),229.9 (219.0 to 241.2),−31.6% (−34.3 to −28.6) *,−34.6% (−39.0 to −27.5) *,−32.6% (−35.4 to −29.2) *
331,All causes,Injuries,Unintentional injuries,"Fire, heat, and hot substances",NA,4060,3380,4770,4400,3560,5210,8460,7030,9880,0.003384,−7.3% (−13.1 to 4.9),−5.2% (−11.2 to 3.9),−6.3% (−11.7 to 1.2),106.3 (88.5 to 124.6),116.3 (94.1 to 136.7),111.1 (92.8 to 129.3),−18.8% (−23.6 to −8.4) *,−16.6% (−21.6 to −8.4) *,−17.7% (−22.4 to −11.0) *
332,All causes,Injuries,Unintentional injuries,Poisonings,NA,2320,1740,2620,1470,1090,1640,3790,2930,4210,0.001516,−12.4% (−20.1 to −0.3) *,−8.2% (−14.8 to 2.6),−10.8% (−17.8 to −0.5) *,60.6 (45.2 to 68.5),39.5 (29.3 to 43.9),50.1 (38.8 to 55.6),−22.4% (−29 to −11.3) *,−18.3% (−24.2 to −8.5) *,−20.9% (−26.9 to −11.7) *
333,All causes,Injuries,Unintentional injuries,Poisonings,Poisoning by carbon monoxide,1040,770,1150,500,329,558,1540,1150,1690,6.16e-4,−19.6% (−27.6 to −11.0) *,−12.8% (−20.8 to −5.4) *,−17.5% (−25.3 to −10.1) *,26.6 (19.7 to 29.4),13.1 (8.6 to 14.7),19.9 (14.8 to 21.9),−29.5% (−36.4 to −21.9) *,−23.3% (−30.3 to −16.6) *,−27.6% (−34.5 to −21.0) *
334,All causes,Injuries,Unintentional injuries,Poisonings,Poisoning by other means,1290,948,1500,966,737,1090,2250,1780,2560,9e-4,−5.6% (−15.0 to 12.3),−5.6% (−13.5 to 6.8),−5.6% (−13.8 to 7.5),34.0 (25.1 to 39.7),26.4 (20.1 to 29.8),30.2 (23.9 to 34.3),−15.7% (−24.1 to 0.8),−15.6% (−22.8 to −4.2) *,−15.7% (−23.2 to −3.7) *
335,All causes,Injuries,Unintentional injuries,Exposure to mechanical forces,NA,8110,6970,9480,3240,2560,3980,11300,9620,13500,0.00452,−3.5% (−8.0 to 1.4),13.6% (7.7 to 20.5) *,0.8% (−3.6 to 5.5),208.5 (179.4 to 243.3),83.8 (66.4 to 102.5),146.1 (124.2 to 172.6),−15.8% (−19.2 to −12.2) *,−2.4% (−7.1 to 2.8),−12.5% (−15.8 to −8.9) *
336,All causes,Injuries,Unintentional injuries,Exposure to mechanical forces,Unintentional firearm injuries,1080,972,1250,334,285,390,1410,1270,1620,5.64e-4,−4.6% (−9.4 to 2.8),11.2% (3.5 to 21.7) *,−1.3% (−5.8 to 4.2),28.0 (25.1 to 32.5),8.7 (7.4 to 10.2),18.4 (16.6 to 21.2),−14.6% (−18.8 to −8.1) *,−2.9% (−9.7 to 6.5),−12.1% (−16.2 to −7.3) *
337,All causes,Injuries,Unintentional injuries,Exposure to mechanical forces,Other exposure to mechanical forces,7030,5970,8340,2900,2260,3600,9930,8310,11900,0.003972,−3.4% (−8.2 to 1.8),13.9% (8.0 to 21.4) *,1.1% (−3.6 to 6.1),180.5 (153.2 to 213.8),75.1 (58.4 to 93),127.6 (107.2 to 152.3),−16.0%% (−19.7 to −12.1) *,−2.3% (−7.1 to 3.3),−12.5% (−16.1 to −8.9) *
338,All causes,Injuries,Unintentional injuries,Adverse effects of medical treatment,NA,2490,2070,3100,2230,1760,2660,4720,3940,5600,0.001888,7.2% (1.0 to 14.4) *,5.5% (0 to 12.3) *,6.4% (1.2 to 13.2) *,66.6 (55.2 to 83.7),58.7 (46.0 to 70.8),62.6 (51.9 to 75.2),−6.7% (−11.9 to −0.8) *,−9.3% (−13.9 to −3.5) *,−7.9% (−12.3 to −2.2) *
339,All causes,Injuries,Unintentional injuries,Animal contact,NA,2650,1630,3090,2340,1180,2870,4990,3180,5830,0.001996,−8.5% (−16.1 to 5.5),0% (−7.8 to 9.9),−4.7% (−10.7 to 3.6),69.3 (42.6 to 81.1),63.2 (31.6 to 77.4),66.1 (42.1 to 77.4),−19.1% (−25.8 to −6.5) *,−11.3% (−18.0 to −2.9) *,−15.6% (−21.2 to −8.0) *
340,All causes,Injuries,Unintentional injuries,Animal contact,Venomous animal contact,2160,1250,2540,1960,898,2450,4120,2490,4910,0.001648,−10.3% (−18.2 to 4.6),−0.4% (−8.8 to 9.3),−5.8% (−11.7 to 2.8),56.6 (32.7 to 66.6),53.1 (23.8 to 66.6),54.7 (32.8 to 65.3),−20.5% (−27.6 to −7.0) *,−11.3% (−18.5 to −3.2) *,−16.4% (−21.9 to −8.5) *
341,All causes,Injuries,Unintentional injuries,Animal contact,Non-venomous animal contact,484,343,612,379,247,648,863,640,1140,3.452e-4,0.3% (−8.5 to 9.4),2.0% (−24.8 to 23.6),1.1% (−16.0 to 10.7),12.7 (9.0 to 16.1),10.1 (6.5 to 17.8),11.4 (8.4 to 15.1),−12.3% (−19.5 to −4.7) *,−11.1% (−33.7 to 7.9),−11.7% (−26.2 to −3.4) *
342,All causes,Injuries,Unintentional injuries,Foreign body,NA,4140,3830,4500,2710,2500,2910,6860,6340,7350,0.002744,−9.0% (−13.1 to −4.5) *,−8.6% (−15 to −3.2) *,−8.8% (−12.6 to −5.0) *,113.7 (104.7 to 123.4),77.0 (70.8 to 82.6),95.4 (88.2 to 102.2),−17.7% (−21.3 to −13.8) *,−17.7% (−23.5 to −12.8) *,−17.7% (−21.2 to −14.3) *
343,All causes,Injuries,Unintentional injuries,Foreign body,Pulmonary aspiration and foreign body in airway,3460,3250,3760,2210,2050,2350,5680,5350,6050,0.002272,−11.4% (−16 to −6.7) *,−11.7% (−18.8 to −5.9) *,−11.5% (−15.7 to −7.4) *,95.8 (89.8 to 104.1),64.1 (59.1 to 68.3),80.0 (75.2 to 85.5),−19.3% (−23.4 to −15.0) *,−19.5% (−26.1 to −14.3) *,−19.4% (−23.3 to −15.6) *
344,All causes,Injuries,Unintentional injuries,Foreign body in eyes,NA,149,76.1,250,52.8,28,85.9,202,105,334,8.08e-5,21.6% (20.0 to 23.8) *,16.7% (15.4 to 18.3) *,20.3% (18.8 to 22.1) *,3.9 (2.0 to 6.5),1.3 (0.7 to 2.2),2.6 (1.3 to 4.3),3.9% (2.6 to 4.7) *,−0.9% (−2.7 to 0.4),2.7% (1.3 to 3.6) *
345,All causes,Injuries,Unintentional injuries,Foreign body in other body part,NA,532,420,657,446,357,547,978,797,1180,3.912e-4,2.1% (−7.5 to 9.6),7.2% (−0.7 to 14.1),4.4% (−1.9 to 10.2),13.9 (11.0 to 17.3),11.5 (9.2 to 14.1),12.7 (10.4 to 15.4),−11.0% (−18.7 to −5.1) *,−7.6% (−14.1 to −1.5) *,−9.6% (−14.7 to −4.7) *
346,All causes,Injuries,Unintentional injuries,Environmental heat and cold exposure,NA,2240,1690,2650,1120,817,1360,3360,2550,4000,0.001344,−9.3% (−13.9 to −5.0) *,2.0% (−3.3 to 6.6),−5.8% (−10.6 to −1.7) *,57.5 (43.2 to 68.2),28.4 (20.5 to 34.7),42.8 (32.4 to 51.1),−22.6% (−26.6 to −19) *,−13.7% (−18.4 to −9.7) *,−19.9% (−24.2 to −16.4) *
347,All causes,Injuries,Unintentional injuries,Exposure to forces of nature,NA,749,624,920,454,370,564,1200,1000,1470,4.8e-4,−18.7% (−25.1 to −11.5) *,−15.6% (−22.6 to −7.8) *,−17.6% (−23.3 to −10.9) *,19.2 (16.0 to 23.5),11.9 (9.7 to 14.8),15.5 (13.0 to 18.9),−27.5% (−33.2 to −21.2) *,−25.8% (−32.0 to −18.8) *,−26.9% (−32.0 to −21.1) *
348,All causes,Injuries,Unintentional injuries,Other unintentional injuries,NA,5950,5220,6860,2640,2110,3340,8580,7380,10200,0.003432,−7.7% (−11.4 to −3.6) *,5.4% (−0.3 to 10.8),−4.0% (−8.2 to 0.4),152.7 (134.1 to 175.9),67.0 (54.1 to 84.1),110.0 (94.9 to 130.3),−19% (−21.9 to −15.8) *,−10.9% (−15.2 to −6.8) *,−16.8% (−19.9 to −13.6) *
349,All causes,Injuries,Self-harm and interpersonal violence,NA,NA,50300,47500,52300,20800,19600,21900,71100,68100,73700,0.02844,8.1% (4.7 to 10.9) *,1.7% (−1.3 to 4.1),6.2% (3.8 to 8.2) *,1278.8 (1206.1 to 1328.3),540.8 (510.6 to 570.7),910.5 (871.7 to 944.2),−4.0% (−7.0 to −1.5) *,−8.6% (−11.2 to −6.3) *,−5.3% (−7.4 to −3.5) *
350,All causes,Injuries,Self-harm and interpersonal violence,Self-harm,NA,22900,20900,24000,11100,10600,11500,34000,31800,35100,0.0136,−0.8% (−6.2 to 3.6),−8.0% (−12.6 to −5.1) *,−3.3% (−6.9 to −0.8) *,577.3 (525.5 to 603.9),282.2 (268.3 to 293),429.0 (401.6 to 443.5),−13.5% (−18.2 to −9.7) *,−18.3% (−22.4 to −15.7) *,−15.1% (−18.3 to −12.9) *
351,All causes,Injuries,Self-harm and interpersonal violence,Self-harm,Self-harm by firearm,2250,1840,2880,405,334,476,2660,2250,3290,0.001064,2.3% (−3.7 to 7.8),−6.2% (−14.1 to 3.1),0.9% (−3.5 to 5.5),57.0 (46.5 to 72.8),10.3 (8.4 to 12.1),33.5 (28.3 to 41.7),−10.6% (−15.5 to −6.1) *,−16.6% (−23.1 to −8.5) *,−11.5% (−15.2 to −7.6) *
352,All causes,Injuries,Self-harm and interpersonal violence,Self-harm,Self-harm by other specified means,20700,18600,21700,10700,10200,11100,31400,29200,32600,0.01256,−1.1% (−6.8 to 3.7),−8.1% (−12.8 to −5.0) *,−3.6% (−7.4 to −1) *,520.3 (467.5 to 546.3),271.9 (258.6 to 282.5),395.4 (368.6 to 410.5),−13.8% (−18.8 to −9.6) *,−18.4% (−22.5 to −15.7) *,−15.4% (−18.7 to −13.1) *
353,All causes,Injuries,Self-harm and interpersonal violence,Interpersonal violence,NA,19800,17800,21000,6250,5370,7230,26000,23700,28000,0.0104,2.0% (−0.7 to 5.2),−2.6% (−5.8 to 2.7),0.9% (−1.4 to 3.6),503.0 (451.5 to 534.9),163.2 (139.9 to 188.5),334.3 (304.7 to 360.5),−8.3% (−10.6 to −5.5) *,−13.0% (−15.8 to −8.2) *,−9.4% (−11.5 to −6.9) *
354,All causes,Injuries,Self-harm and interpersonal violence,Interpersonal violence,Assault by firearm,8690,7330,9500,968,804,1140,9660,8230,10400,0.003864,6.8% (3.3 to 10.8) *,−4.5% (−8.6 to 1.3),5.5% (2.4 to 9.2) *,221.5 (186.8 to 242.3),25.4 (21.0 to 30.0),124.4 (105.8 to 134.0),−2.7% (−5.8 to 1.0),−13.6% (−17.2 to −8.4) *,−3.7% (−6.6 to −0.4) *
355,All causes,Injuries,Self-harm and interpersonal violence,Interpersonal violence,Assault by sharp object,4150,3240,5180,959,792,1100,5110,4170,6160,0.002044,−11.8% (−15.8 to −6.2) *,−12.6% (−15.7 to −7.4) *,−11.9% (−15.5 to −7.1) *,105.1 (81.7 to 131.1),24.8 (20.4 to 28.3),65.2 (53.2 to 78.5),−21.0% (−24.6 to −16.0) *,−22.1% (−25 to −17.5) *,−21.2% (−24.3 to −16.9) *
356,All causes,Injuries,Self-harm and interpersonal violence,Interpersonal violence,Sexual violence,370,248,540,1770,1190,2570,2140,1450,3110,8.56e-4,9.4% (7.7 to 11.1) *,13.0% (10.7 to 15.1) *,12.4% (10.2 to 14.3) *,9.4 (6.3 to 13.8),45.4 (30.6 to 66.1),27.3 (18.5 to 39.7),−1.7% (−2.3 to −1.0) *,1.0% (−0.2 to 2.3),0.6% (−0.6 to 1.6)
357,All causes,Injuries,Self-harm and interpersonal violence,Interpersonal violence,Assault by other means,6540,5750,7730,2550,2140,2990,9090,8190,10400,0.003636,5.9% (0.6 to 11.5) *,−6.9% (−11.3 to 1.5),1.9% (−1.9 to 6.2),167.0 (147.0 to 197.4),67.6 (56.2 to 79.4),117.4 (105.7 to 134.4),−6.2% (−10.6 to −1.3) *,−17.0% (−20.9 to −9.2) *,−9.5% (−12.9 to −5.8) *
358,All causes,Injuries,Self-harm and interpersonal violence,Conflict and terrorism,NA,6840,6400,7830,3270,2820,3870,10100,8980,11400,0.00404,81.9% (55.6 to 112.4) *,70.8% (48.8 to 99.3) *,78.1% (58.6 to 101.2) *,177.1 (155.8 to 203.0),90.6 (78.2 to 107.0),134.1 (119.3 to 151.9),66.2% (42.8 to 94.5) *,58.4% (36.9 to 86.4) *,63.7% (45.4 to 85.1) *
359,All causes,Injuries,Self-harm and interpersonal violence,Executions and police conflict,NA,840,800,894,179,170,190,1020,972,1080,4.08e-4,140.7% (123.6 to 160.4) *,280.6% (245.5 to 309.1) *,157.3% (139.7 to 178.0) *,21.4 (20.4 to 22.8),4.8 (4.5 to 5.1),13.1 (12.6 to 13.9),117.3% (101.5 to 1,NA,NA
